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ABSTRACT
We have previously identified σS, an ECF sigma factor that is important in the virulence
and stress response of S. aureus. Transcriptional profiling of sigS revealed that it is
differentially regulated in a variety of laboratory and clinical strains of S. aureus,
suggesting that there exists a regulatory network that modulates its expression. In order
to identify direct regulators of sigS expression, we performed a biotin pull down assay in
tandem with mass spectrometry. We identified CymR as a direct regulator and observed
that sigS expression is increased in cells lacking cymR. In addition, transposon
mutagenesis was performed to identify regulators of sigS expression. We identified
insertions in genes that are transcriptional regulators, and elements involved in amino
acid biosynthesis and DNA replication, recombination and repair as influencing sigS
expression.

Finally, methyl nitro-nitrosoguanidine mutagenesis in conjunction with

whole genome sequencing was employed and revealed mutations in the lactose repressor,
lacR, and the membrane sensor histidine kinase, kdpD, as negatively effecting sigS
expression. EMSAs revealed that LacR is an indirect regulator of sigS expression, while
the response regulator KdpE is a direct repressor. These results indicate that a complex
regulatory network is in place for sigS that modulates its expression.
In a continuation of studies on σS regulation, we next explored interplay with the products
of genes conserved within the sigS locus. We determined that this region is conserved
amongst all the sequenced staphylococci, and includes four genes: SAUSA300_1721 (a
conserved hypothetical protein), as well as sigS, ecfX, and ecfY. In order to investigate
!
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the relationship between EcfX and σS we performed protein pull down assays and
observed that these two protein interact. Further to this, transcriptional analysis of sigS in
an ecfX mutant reveal that expression of sigS is decreased, indicating that it is an
activator. Architectural analysis of the sigS locus via RNAseq revealed that the majority
of transcription in this region comes from ecfY, a gene that is downstream and divergent
to sigS. We demonstrate that inactivation of ecfY leads to a significant increase in sigS
expression, and that ecfY null strains are more resistant to DNA damaging agents such as
UV, H2O2, MMS, and ethidium bromide, which we have previously demonstrated that a
sigS mutant is highly sensitive to. Our studies also revealed that an ecfY null strain is
better able to survive intracellularly following phagocytosis by RAW 264.7 cell and
demonstrates increased survival in whole-human blood, which is again opposed to that
previously observed for sigS deficient strains. Because the ecfY null strain overexpresses
sigS, we investigated the regulon of this sigma factor using this mutant in conjunction
with RNAseq analysis. We identified that genes putatively under the control of σS are
involved in DNA damage and repair, virulence, amino acid starvation and nucleic acid
biosynthesis.

Collectively, our results indicate that σS is regulated via a unique

mechanism: positively through an apparent need for an activator protein (EcfX) and
negatively via RNA-RNA interaction (the 3’ UTR of ecfY).

We suggest that the

evidence presented here greatly adds not only to our understanding of the regulatory
circuits extant within S. aureus, but also to alternative sigma factor biology in general.
Finally, we evaluated the efficacy of a novel library of quinazoline-based compounds
against a highly drug resistant strain of S. aureus. We performed structure activity and
structure property relationship assays in order to identify lead compounds.
!
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These

methods lead to the identification of N2,N4-disubstituted quinazoline-2,4-diamines that
had low minimum inhibitory concentrations, along with favorable physiochemical
properties. Evaluation of their biological activity demonstrated limited potential for
resistance of to our quinazoline based compounds, low toxicity to human epithelial cells,
and strong efficacy in vivo. Taken together, our findings support the use of quinazoline
derivatives as potential new antimicrobials against multidrug resistant S. aureus.
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CHAPTER ONE:
INTRODUCTION
Staphylococcus aureus. Staphylococcus aureus, first discovered by Sir Alexander Ogston in
1882, belongs to the bacterial family Staphylococcaceae. S. aureus is a Gram-positive, nonspore forming, non-motile opportunistic pathogen that can inhabit soil, water and air. It has also
been reported that this organism can be found colonizing nearly every surface in hospitals, day
care centers, schools, military barracks, locker rooms and weight rooms (Begier et al., 2004;
Hewlett, Falk, Hughes, & Mayhall, 2009; (Montgomery, Ryan, Krause, & Starkey, 2010)
(Morrison-Rodriguez, Pacha, Patrick, & Jordan, 2010); (Oller, Province, & Curless, 2010). S.
aureus exists as both a commensal of human beings and a pathogen. Indeed, approximately 50%
of the population harbors this bacterium in their anterior nares (Frank et al., 2010). S. aureus can
also be found colonizing skin folds, the perineum, the axillae, and the vagina (Williams, 1963)
(Armstrong-Esther, 1976) (Guinan et al., 1982). Close quarter communities have an increased
risk of infection with this organism as transmission is mediated through person-to-person contact
and by contact with contaminated equipment (Ben-David, Mermel, & Parenteau, 2008). S.
aureus has the ability to infect almost any ecological niche within the human body, causing a
wide range of diseases. Infections caused by S. aureus typically begin as localized skin and soft
tissue infections, such as folliculitis, furuncles, carbuncles, and impetigo. Once this organism
breaches the outer barrier of the body, it can then disseminate to other sites, and cause more
severe invasive infections such as endocarditis, meningitis, osteomyelitis, and pneumonia. It can
also cause a number of toxinoses that include food poisoning and toxic shock syndrome, which
!

1!

are brought about through the action of individual toxins produced by the bacterium (Brook,
2009) (Chambers, Korzeniowski, & Sande, 1983) (Goundan, Mehrotra, Mani, & Varadarajan,
2010; Kempker, Difrancesco, Martin-Gorgojo, & Franco-Paredes, 2009) (Musher et al., 1994)
(Sheehy et al., 2010) (Troidle, Eisen, Pacelli, & Finkelstein, 2007).
Antibiotic Resistant S. aureus. The success of S. aureus is due, in large part, to its rampant
resistance to antibiotics, especially those of the β-lactam family, which includes penicillin
(Graves, Kobayashi, & DeLeo, 2010). Indeed, prior to the use of antibiotics, approximately 80%
of staphylococcal blood-borne infections were fatal.

Two years after the introduction of

penicillin, S. aureus resistance was reported (Kirby, 1945). S. aureus circumnavigates the action
of penicillin by using the enzyme β-lactamase, also called penicillinase. For the β-lactam class
of antibiotics, the bactericidal activity is due to the β-lactam ring, which binds and inhibits
essential transpeptidase enzymes, which are responsible for catalyzing the cross-linkage of two
peptidoglycan subunits in the final step of cell-wall biosynthesis (Wise & Park, 1965). βlactamases work by cleaving the β-lactam ring, destroying the inherent antimicrobial activity
(Sykes & Matthew, 1976). In 1959, methicillin, the first synthetic derivative of penicillin, was
used to treat antibiotic resistant strains of S. aureus.

The presence of the ortho-

dimethyoxyphenyl side chain in this drug provides steric hindrance, which protects the β-lactam
ring from β-lactamase activity (Simon, 1962).

In 1961, the world saw the emergence of

methicillin-resistant Staphylococcus aureus (Klevens et al.), which is also known as multi-drug
resistant S. aureus (Eriksen & Erichsen, 1963). Accordingly, MRSA strains are resistant to the
entire β-lactam family of antibiotics because of the acquisition of a genomic island that included
a mecA gene, which encodes a transpeptidase that does not have affinity for β-lactam antibiotics
(Hartman & Tomasz, 1984) (Hiramatsu, Cui, Kuroda, & Ito, 2001) (Reynolds & Brown, 1985)
!
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(Utsui & Yokota, 1985). In 1958, the FDA approved the use of vancomycin, a glycopeptide
antibiotic that inhibits cell wall synthesis in bacteria. Vancomycin was not commonly used as a
first line of defense for treating staphylococcal infection however, because it has to be
administered intravenously, and has serious side effects associated with its use (Dutton & Elmes,
1959). With that said, the unwillingness to deploy vancomycin as a commonplace treatment for
MRSA infections eroded through the 1980s and 90s as a result of it efficacy against these strains.
Unfortunately, in 1997, reports of vancomycin intermediate S. aureus (VISA) strains began to
appear, which, while still susceptible to the drug, required significantly higher doses to eradicate.
In 2002 true vancomycin resistant S. aureus (VRSA) was reported in Michigan (Tenover et al.,
2004). It is believed that the genetic resistance to vancomycin was acquired via conjugation from
the Enterococcaceae family, which are highly resistant to this drug (Livermore, 2007).
Hospital-Acquired and Community-Acquired S. aureus.

Historically, the majority of

infections caused by MRSA have been hospital acquired (HA-MRSA), and occur in those who
have a history of hospitalization and immunosupression (Naimi et al., 2003).

HA-MRSA

infections often require a longer hospital stay and more expensive treatments, as the mortality
rates associated with them are usually very high (Klevens et al., 2007). An increase in nonclinical associated MRSA infections was first reported in the early 1990’s in Western Australia.
These were caused by so-called community acquired Methicillin Resistant S. aureus (CAMRSA), which are seemingly more aggressive, pathologically, than HA-MRSA (Popovich,
Weinstein, & Hota, 2008). In 1997, CA-MRSA claimed the lives of four children in the
Midwest United States (Klevens et al., 2007), signaling the start of a national epidemic, which
appears to be spreading globally (Kobayashi & DeLeo, 2009). Preceding this, in the early
1980’s, an aggressive but isolated strain of MRSA was reported among drug users in Detroit;
!
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however, these cases are not related to the CA-MRSA of the late 1990’s (Klevens et al., 2007).
While HA-MRSA strains typically cause chronic infections, CA-MRSA strains are more
aggressive in their pathogenesis. The more aggressive nature of CA-MRSA strains can be
attributed to differences in gene expression (G. Y. Cheung, Wang, Khan, Sturdevant, & Otto,
2011). Specifically, in CA-MRSA strains the major virulence regulator, agr, which controls the
expression of toxins and proteases, was found to be more highly expressed in comparison to HAMRSA strains (G. Y. Cheung et al., 2011). CA-MRSA is responsible for infections among
young healthy individuals that have no predisposing complications and who commonly live in
close quarters, such as prison-inmates, children, aboriginal populations, military personnel,
Native Americans and athletic teams (Popovich et al., 2008). CA-MRSA is reported to be the
most common cause of infection seen in emergency rooms in the United States (Kobayashi &
DeLeo, 2009), and recent studies have suggested that these strains may even be replacing
traditional HA-MRSA strains in clinical environments (Popovich et al., 2008).

It is now

estimated that MRSA causes more deaths annually than HIV/AIDS in the United States
(Kobayashi & DeLeo, 2009). Indeed, MRSA also causes more infections than Streptococcus
pneumoniae¸ Neisseria meningitidis, and Haemophilus influenzae combined (Klevens et al.,
2007). Furthermore, these observations are for MRSA strains, and do not consider the number of
cases reported to be caused by methicillin sensitive S. aureus (MSSA) (Rehm & Tice, 2010). Of
very real concern is the observation that the number of infections caused by MSSA strains is
estimated to be twice as many as MRSA (Rehm & Tice, 2010).
Although, CA-MRSA strains are clinically more aggressive than HA-MRSA strains, they have
thus far proven susceptible to non-β-lactam antibiotics (Naimi et al., 2003). However, there have
been recent reports of CA-MRSA that are increasingly resistance to antibiotic treatment. In a
!

4!

study conducted by Han et. al. CA-MRSA strains were isolated that were resistant to
erythromycin, clindamycin, levofloxacin and tetracycline (Han et al., 2007). Of even greater
concern is the identification in the United States of VISA isolates from the leading communityassociated MRSA lineage, USA300 (Diep et al., 2008).
Virulence Determinates of S. aureus. The success of infection is dependent upon the ability of
an organism to invade and colonize the host. S. aureus has the unique ability invade and
colonize almost every ecological niche of the human body. This is mediated by the virulence
determinants that are encoded in the S. aureus genome, and are largely distinguished by those
associated with the cell wall/envelope, and those secreted into the extracellular milieu.
Cell Wall Associated Virulence Determinants. In order to facilitate colonization, and therefore
infection, S. aureus encodes a number of microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs). MSCRAMMs are membrane-associated molecules that are
responsible for recognizing and binding to the extracellular matrix (ECM) of the host. The ECM
provides structural support to the host and is made up of a variety proteins that include
fibrinogen, collagen and fibronectin. S. aureus encodes two factors, clumping factor A (ClfA)
and clumping factor B (ClfB), that are responsible for recognizing and binding to fibrinogen
during early infection (McDevitt, Francois, Vaudaux, & Foster, 1994) (O'Brien, Walsh, Massey,
Peacock, & Foster, 2002). ClfA is the primary fibrinogen binding protein as it is expressed
across all growth phase, whereas ClfB is expressed during early logarithmic growth (McDevitt et
al., 1994) (Ní Eidhin et al., 1998). In addition, S. aureus mutants lacking clfA are attenuated in
virulence in rabbit models of endocarditis, indicating the importance of fibrinogen mediated
adhesion (Moreillon et al., 1995). In addition to the Clf proteins, S. aureus encodes two
fibronectin-binding proteins, FnBPA and FnBPB that bind to fibronectin (Greene et al., 1995)
!
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(Jonsson, Signas, Muller, & Lindberg, 1991). Fibrinogen binding mediated by FnBPA and
FnBPB greatly enhanced the ability of S. aureus to establish infection in a rat model of
endocarditis (Kuypers & Proctor, 1989). Additionally, it had previously been demonstrated that
S. aureus can be internalized by nonprofessional phagocytes and cause persistent, chronic
infections (Almeida, Matthews, Cifrian, Guidry, & Oliver, 1996) (Bayles et al., 1998).
Dziewanowska et. al has demonstrated that this interaction between nonprofessional phagocytes
and S. aureus cells is mediated through the FnBPA and FnBPB, as mutants lacking the ability to
bind to fibrinogen were not internalized (Dziewanowska et al., 1999). S. aureus’ ability hide
inside nonprofessional macrophages contributes to long term colonization and thus chronic
infections. In order to circumvent the immune system once an infection has been established, S.
aureus employs a number of immune evasions strategies.

One such way is through the

production of a capsule, which is a thin polysaccharide layer that surrounds the cell. There are
11 different serotypes of S. aureus with regards to capsular polysaccharides, but type 5 and 8 are
the most predominant forms (Cocchiaro et al., 2006) (Na'was et al., 1998) (Verdier et al., 2007)
(von Eiff et al., 2007). Capsules protect the bacterium during infection because they are resistant
to opsonization, which is the process of the immune system marking bacteria for phagocytosis
(van Kessel, Bestebroer, & van Strijp, 2014). Another immune evasion strategy used by S.
aureus is the production of surface protein A. Surface protein A is both a surface associated and
secreted protein that binds to the Fc region of IgG, which is the major antibody in circulation
(Uhlen et al., 1984). By binding to the Fc region of IgG, S. aureus inverts the antibody in the
incorrect orientation, thus circumventing phagocytosis by professional phagocytic cells (Uhlen et
al., 1984). Patel et. al. demonstrated that mutants lacking spa were more easily phagocytosed by
neutrophils, and that they are attenuated in virulence, highlighting the importance of immune
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evasion during infection (Patel, Nowlan, Weavers, & Foster, 1987).
Secreted Virulence Factors of S. aureus. Continuing with the theme of immune evasion, S.
aureus secretes four bi-component toxins that are responsible for forming pores in host immune
cells. The Panton-Valentine Leukocidin (PVL) specifically targets neutrophils, macrophages,
and monocytes, and contributes to virulence in rabbit models of skin infection (Lipinska et al.,
2011). The γ-hemolysin is responsible for targeting monocytes and polynuclear leukocytes, and
is the only leukocidin that effectively lyses red blood cells, thereby contributing to growth in
blood, and virulence in murine models of septic arthritis (Malachowa et al., 2011) (Nilsson,
Hartford, Foster, & Tarkowski, 1999). Leukocidin ED (LukED) was discovered over a decade
ago but remains the least studied of the pore-forming toxins. LukED is responsible for lysing
polymorphonuclear (PMNs) leukocytes and it has also recently been demonstrated as
contributing to virulence in murine models of septicemia (Alonzo et al., 2012) (Gravet et al.,
1998). While PVL, γ-hemolysin and leukocidinED are all secreted, leukocidin AB (LukAB) is
both secreted and associated with the cell surface (Ventura et al., 2010). LukAB is responsible
for lysing neutrophils, dendritic cells, macrophages and monocytes (Dumont et al., 2011), and
contributes to the survival of S. aureus upon phagocytosis by human neutrophils (Dumont et al.,
2011).

Another virulence factor that acts to lyse immune cells is a class of secreted

staphylococcal peptides called phenol-soluble modulins (PSM). The S. aureus genome encodes
two types of these amphipathic, α-helical peptides, PSMα and PSMβ, which have been shown to
be involved in facilitating the release of S. aureus post phagocytosis and contribute to the
pathogenesis of this organism (Otto, 2014).
Once an infection is established and S. aureus has exhausted local nutrient sources, it employs
toxins and proteases to facilitate tissue destruction for nutrients and dissemination to other parts
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of the host. Production of α-toxin is one such way for S. aureus to cause damage to host cells.
This toxin associate as a hexamer on the surface of red blood cells and results in the formation of
pores in the membrane, which lead to the destruction of host tissues (Bhakdi & Tranum-Jensen,
1991). In addition, S. aureus secretes 10 extracellular proteases that contribute to the destruction
of host tissues. These include six serine-like proteases (SplABCDEF), two cysteine proteases
(ScpA and SspB), V8 serine protease (SspA), and a metalloprotease (Aur). Recently a study was
conducted with a strain that lacked all 10 proteases and found that this strain was hypervirulent
and that they contribute to the stability of other secrete virulence determinants (Kolar et al.,
2013).

In addition, these extracellular proteases play a role in evading the host immune

response.
Regulation of Virulence Determinate Expression. S. auerus virulence determinants are
regulated in a complex multifactorial network that includes two-component regulators, DNAbinding proteins, regulatory RNAs and alternative σ factors. The S. aureus quorum sensing twocomponent regulatory system, agr, plays an important role in the pathogenesis of S. aureus as it
mediates the temporal shift from expressing surface proteins to the secretion of proteases and
toxins (Janzon, LÃ¶fdahl, & Arvidson, 1986), (Ji, Beavis, & Novick, 1995). This switch occurs
as the organism shifts from exponential growth to stationary phase, and is a way to overcome
depletion of nutrients (Janzon et al., 1986), (Ji et al., 1995). The agr system controls the
expression of a regulatory RNA, known as RNAIII that subsequently controls the expression of
surface proteins and exoproteins (Janzon et al., 1986), (McNamara, Milligan-Monroe, Khalili, &
Proctor, 2000).

This regulatory RNA negatively impacts the translation of many surface

associated proteins, such as surface protein A and coagulase, by binding to their mRNA
transcripts directly, preventing translation and ultimately recruiting endoribonuclease III
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(Huntzinger et al., 2005), (A. Cheung et al., 2010). Additionally, RNAIII binds to and prevents
the translation of Rot (repressor of toxins), which is responsible for repressing toxins and
proteases (McNamara et al., 2000).

Another important regulator of virulence determinant

expression is the DNA-binding protein, SarA (A. L. Cheung, Nishina, Trotonda, & Tamber,
2008). This global regulator brings about changes in gene expression of cell surface associated
and secreted proteins in an agr-independent and agr-dependent manner (A. L. Cheung et al.,
2008). In addition, sarA plays a significant role in represing extracellular proteases, whose
activity severely limit S. aureus’ ability to form biofilms (Atwood et al., 2015). (Beenken,
Blevins, & Smeltzer, 2003).

The S. aureus genome also encodes sixteen two-component

systems, a number of which play a role in regulating virulence determinants.

The two-

component system SaeRS is responsible for directly controlling the expression of the
extracellular nuclease, nuc, which was found to be important in the pathogenesis in a lung model
of infection and in evading neutrophil extracellular traps (Van Horn et al.) (Olson et al., 2013),
(Berends et al., 2010). Additoinally, SaeRS is also responsible for controlling the expression of
α-hemolysin and proteases (D. Li & Cheung, 2008), (Rogasch et al., 2006). The two-component
system ArlRS either directly or indirectly regulates the expression of 118 genes, which include a
number of virulence-associated factors, such as delta-hemolysin and the major virulence
regulator, agr (Liang et al., 2005).
Sigma Factors. Transcription of DNA to RNA is performed by the multisubunit enzyme RNA
polymerase, or RNAP. Bacterial RNAP consists of a β, β’, two identical α subunits, ω and a
dissociable factor called the sigma factor (Gruber & Gross, 2003), (Ishihama, 2000). In addition,
Gram-positive bacteria encode two other accessory subunits, ε and δ (Burgess, 1969), (Keller et
al., 2014), (Pero, Nelson, & Fox, 1975).
!

Sigma factors play a central role in promoter
9!

recognition and promoter melting, without them there would be no transcription. Sigma factors
belong to two large, unrelated protein families, σ70 and σ54 (Helmann & Chamberlin, 1988). The
σ54 family of sigma factors has mainly been associated with nitrogen utilization, however it is
also involved in dicarboxylic acid transport, toluene and xylene catabolism, hydrogenase
biosynthesis and pilus production (Merrick, 1993). This family of sigma factors is relatively
widespread, although not ubiquitous, as none having been identified in high G-C Gram-positive
bacteria or cyanobacteria (Gruber & Gross, 2003), (Patek & Nesvera, 2011), (Sachdeva, Misra,
Tyagi, & Singh, 2010), (Wosten, 1998). For those species that encode σ54 sigma factors, there
usually exists one copy, with the exception of Bradyrhizobium japonicum, Rhodobacter
sphaeroides, and Rhizobium etli, which encode two

(Choudhary, Mackenzie, Mouncey, &

Kaplan, 1999), (Kullik et al., 1991), (Michiels, Moris, Dombrecht, Verreth, & Vanderleyden,
1998). Unlike the σ70 family of sigma factors, which can associate with RNAP and initiate
transcription without additional proteins, the σ54 family cannot initiate open complex formation
without the presence of an activator protein, which binds anywhere from 100 to 1000 nucleotides
upstream of target promoters

(Buck, Miller, Drummond, & Dixon, 1986), (Reitzer &

Magasanik, 1986).
The σ70 family is the major class of σ factors and are typically characterized by 4 general
domains (Figure 1), however only two are essential for activity (regions 2 and 4), and are
absolutely conserved across all members (M. Lonetto, Gribskov, & Gross, 1992), (Wosten,
1998). Region 1 prevents the σ factor from binding indiscriminately to DNA without RNAP,
and is thus considered inhibitory to
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Figure 1. Schematic representation of the four domains of the σ70 subfamily of sigma
factors. Region σ1 is responsible for inhibiting sigma factor binding to promoter regions in the
absence of RNAP. Region σ3 interacts with DNA upstream of the -10 consensus sequence at socalled extended -10 sites. Regions σ2 and σ4 are the most highly conserved and are responsible
for
recognizing
the
-10
and
-35
consensus
sequences,
respectively.
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function (Helmann & Chamberlin, 1988). Region 2 can be further broken down into 4 subregions that collectively facilitate promoter melting: Regions 2.1 and 2.2 are required for
binding to core-RNAP, region 2.3 is responsible for promoter melting, and region 2.4 directly
interacts with the -10 consensus sequence of the promoter (Aiyar, Juang, Helmann, & deHaseth,
1994), (Joo, Ng, & Calendar, 1997), (Shuler, Tatti, Wade, & Moran, 1995), (Tatti, Shuler, &
Moran, 1995). Region 3 of σ70 factors interacts with DNA upstream of the -10 consensus
sequence at so-called extended -10 regions (Helmann & Chamberlin, 1988). Region 4 contains a
helix turn helix (HTH) domain that is responsible for recognition of the -35 consensus sequence,
and is also responsible for interacting with the β-subunit to result in HTH association with the 35 consensus sequence (Campbell et al., 2002), (Helmann & Chamberlin, 1988), (Murakami &
Darst, 2003). The σ70 family can be broken down into 5 different groups (Table 1): Group 1
sigma factors are the primary sigma factors (Helmann, 2002), which are control the majority of
transcription in rapidly growing bacterial cells, and are essential, with the exception of
Chlorobium tepidum (Kill et al., 2005). Interestingly, in this particular bacterium there is a
frame shift mutation in the gene encoding the housekeeping sigma factor, which leads to a
truncated protein. It is unclear as to how C. tepidum survives without a primary sigma factor to
direct transcription; however, it can be hypothesized that there exist alternative sigma factors that
direct the transcription of housekeeping genes. Group 2 are nonessential paralogs of group 1,
which, as with group 1, also contain all four of the conserved sequence regions. In addition,
there is likely overlap in promoter recognition between group 1 and 2 sigma factors because the
regions that determine promoter selectivity are nearly identical (Helmann, 2002).

Group 3

sigma factors can be further divided into three evolutionarily related clusters; a heat shock
cluster, a flagellar biosynthesis cluster, and a sporulation cluster (Helmann, 2002). Group 4
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Table 1. Subfamilies of σ 70 sigma factors.
Group
Function
Examples
1
Primary or Housekeeping sigma factors. They σA of B. subtilis; σ70 of E. coli
are responsible for a majority of transcription in
the cell.
2
Nonessential homologs of primary sigma factors σD of S. coelicolor; σS of E. coli
3
Secondary sigma factors
σ28 of S. coelicolor; σ28 of S.
typhimurium
4
Extracytoplasmic function (ECF) sigma factors
σE of S. coelicolor; σE of E. coli
5
TxeR subfamily; Regulate toxin production
TxeR of C. difficile
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sigma factors are known as extracytoplasmic function (ECF) sigma factors and typically respond
to environmental stress (M. Lonetto et al., 1992). This group is the most structurally diverse in
that it lacks both regions 1 and 3 (Helmann, 2002), (M. Lonetto et al., 1992). Group 5 sigma
factors were identified in 2001 in Clostridium difficile and are commonly involved in the
regulation of toxin production (Helmann, 2002), (Mani, 2001).
Extracytoplasmic Function (ECF) Sigma Factors.

There were two separate lines of

investigation that led to the discovery of the ECF subfamily of sigma factors. Work by the
Buttner group identified sigE of Streptomyces coelicolor, describing it as having only distant
similarity to other known sigma factors (Helmann, 2002). In 1994, Lonetto et al. characterized
σE of S. coelicolor and noted that there was a high degree of similarity to σE of Escherichia coli,
AlgU of Pseudomonas aeruginosa, CarQ of Myxococcus xanthus, FecI of E. coli, HrpL of P.
syringae, CnrH of Alcaigenes eutrophus and SigX of Bacillus subtilis; suggesting that these
transcription factors make up a subfamily of sigma factors that respond to extracytoplasmic
stimuli (M. A. Lonetto, Brown, Rudd, & Buttner, 1994). Since their discovery, it has been
observed that ECF sigma factors are the largest subfamily of sigma factors with an average of six
such elements present per bacterial genome (Staron et al., 2009). Indeed, ECF sigma factors
outnumber in representatives all other subfamilies of sigma factors combined. As a general
trend, the amount of ECF sigma factors per bacterial genome increase with genome size and the
complexity of an organism’s lifestyle. While ECF sigma factors are restricted to prokaryotes,
they are often described as ubiquitously distributed in bacterial species, although none have been
identified in any of the currently sequenced genomes of the Aquificae, Chlamydiae, Rikettsiales
phyla, or the genera of Borrelia and Mycoplasma, all of which are either obligate symbionts or
pathogens with genomes that are less than 2 million base pairs (Staron et al., 2009). The phyla
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with the most ECF sigma factors are Acidobacteria, Actinobacteria and Bacteroidetes with an
average of 40-50 per genome (Staron et al., 2009). Notably, however, the δ-proteobacteria,
Sorangium cellulosum, has 83 identified ECF sigma factors; although this is perhaps
unsurprising as this bacterium also has the largest prokaryotic genome identified to date, with
over 13 million base pairs (Schneiker et al., 2007).
As described above, the σ70 family of sigma factors is structurally characterized as having four
distinct regions that are responsible for bringing about transcription (Helmann, 2002), (M.
Lonetto et al., 1992), (Wosten, 1998). However, ECF sigma factors are unique in that they only
contain the most conserved regions, 2 and 4 (Helmann, 2002). Typically, ECF sigma factors are
characterized by three common hallmarks: The first is that they usually recognize an AAC motif
and a grouping of CGTs in the -35 and -10 consensus sequences of promoter regions,
respectively (Helmann, 2002), (Lane & Darst, 2006). Secondly, it is not uncommon to find ECF
sigma factors transcriptionally linked to a cognate transmembrane anti-sigma factor, which acts
as an antagonist to the sigma factor by sequestering it and preventing it from initiating
transcription (Helmann, 1999). Lastly, ECF sigma factors control the transcription of genes that
are involved in transport, or in responding to stress caused to the cell envelope (Helmann, 2002),
(M. Lonetto et al., 1992). While these characteristics have held true for ECF sigma factors over
the last decade, we are now beginning to see a shift in the ECF paradigm, whereby, as more are
discovered, we observe that they are often flanked by conserved genes that could indicate a novel
mechanism of regulation distinct from the anti-sigma factor partner switching mechanism. An
example of this comes from sigJ in M. tuberculosis, which is flanked by oxidoreductases genes
that are hypothesized to be involved in regulating this sigma factor by an unknown mechanism
(Staron et al., 2009), (Hu, Kendall, Stoker, & Coates, 2004). In addition, as the number of ECF
!

15!

sigma factors identified grows, it becomes apparent that there also exist a subset of ECF sigma
factors that are responsible for sensing and responding to cytoplasmic stress, as indicated by the
presence of soluble anti-sigma factors (Dufour, Landick, & Donohue, 2008), (Gunesekere et al.,
2006), (Mark S. B. Paget & Helmann, 2003), (Ward, Lew, Treuner-Lange, & Zusman, 1998),
(Wu, Kong, Lam, & Husson, 1997).
Role of ECF Sigma Factors in Cell Physiology. With the number of ECF sigma factors
growing each year, it is now thought that they represent one of the top three signal transduction
mechanisms in bacterial genomes, behind one and two component systems (Staron et al., 2009).
This stands to reason because the use of alternative sigma factors represents an efficient and
powerful way to change gene expression as they are typically transcribed and translated, but held
inactive by cognate anti-sigma factors until an appropriate stress is detected (Helmann, 2002),
(M. Lonetto et al., 1992). Historically, ECF sigma factors have been known to function in
controlling the expression of genes involved in responding to environmental stress, such as, but
not limited to, oxidizing agents, antimicrobial peptides, heat shock, iron stress and nutrient
limitation. One of the most well characterized ECF sigma factors is σE of E. coli. In E. coli, σE
is responsible for the transcription of 40 genes that are involved in maintaining the integrity of
the cell envelop in response to periplasmic stress, such as improperly folded proteins (De Las
Penas, Connolly, & Gross, 1997), (Erickson & Gross, 1989), (Missiakas, Mayer, Lemaire,
Georgopoulos, & Raina, 1997), (Wang & Kaguni, 1989). In addition to being involved in
maintaining cell envelope integrity, σE is also involved in the heat shock response by controlling
transcription of the P3 promoter of rpoH (Erickson & Gross, 1989), (Missiakas et al., 1997),
(Wang & Kaguni, 1989). The rpoH gene encodes the heat shock sigma factor, σ32, which
controls the expression of genes involved in combating elevated temperatures (Grossman,
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Erickson, & Gross, 1984). In addition to being one of the most well characterized ECF sigma
factors, σE is also one of the most well conserved, as homologs have been identified in S.
coelicolor, Salmonella typhimurium, Mycobacteria tuberculosis, Haemophilus influenza and
Psuedomonas aeruginosa, (Craig, Nobbs, & High, 2002), (Humphreys, Stevenson, Bacon,
Weinhardt, & Roberts, 1999), (M. Lonetto et al., 1992), (Martin, Holloway, & Deretic, 1993),
(R. Manganelli, Dubnau, Tyagi, Kramer, & Smith, 1999; R. Manganelli, Voskuil, Schoolnik, &
Smith, 2001).
In S. coelicolor, σE is also involved in maintaining the integrity of the cell envelope (Hutchings,
Hong, Leibovitz, Sutcliffe, & Buttner, 2006), however, unlike in E. coli, σE in S. coelicolor is
also active in maintaining cell envelope integrity under standard conditions (Hutchings et al.,
2006).

In S. typhimurium, σE is not required for survival of the pathogen at elevated

temperatures (Humphreys et al., 1999), however mutants lacking this element are less able to
survive than the parental strain when grown in the presence of alternative carbon sources, and
when exposed to oxidizing agents (such as hydrogen peroxide and superoxide) and antimicrobial
peptides (Humphreys et al., 1999). σE is also one of the ten ECF sigma factors encoded within
the genome of M. tuberculosis, and is the best characterized of these transcription factors. Like
E. coli, σE in M. tuberculosis is involved in the response to heat shock (R. Manganelli et al.,
1999; R. Manganelli et al., 2001), but is also important in the cells response to vancomycin,
oxidative stress, and the detergent sodium dodecyl sulfate (SDS) (R. Manganelli et al., 2001).
The σE encoding gene is also highly conserved in other species of Mycobacterium, such as M.
smegmatis, M. bovis, M. leprae, M. avium, and M. fortuitum, where it has been experimentally
demonstrated to be involved in the response to acid shock, heat shock, oxidative stress, and
detergents (Wu et al., 1997). While there has been very little research into the role that σE has in
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the life-style of H. influenzae, it has been demonstrated that this ECF sigma factor is important
for intracellular survival in murine derived macrophages, indicating its importance during the
pathogenesis of this organism (Craig et al., 2002). AlgU, the σE homolog in P. aeruginosa, is
involved in alginate biosynthesis, oxidative stress, heat shock, osmotic stress, cell wall stress and
immune evasion (Aspedon, Palmer, & Whiteley, 2006), (Firoved & Deretic, 2003), (Potvin,
Sanschagrin, & Levesque, 2008), (Wood, Leech, & Ohman, 2006; Wood & Ohman, 2009).
More recent studies have demonstrated that AlgU is also important in the ability of the
nonmucoid form of P. aeruginosa to form biofilms (Bazire et al., 2010).

In addition, P.

aeruginosa mutants lacking algU demonstrate a decrease in motility, which is an important
function in colonization of the lungs (Bazire et al., 2010). However, these decreases in biofilm
formation and motility are not a result of direct control of AlgU on key biofilm and motility
genes, but control of their regulators instead (Bazire et al., 2010).
One of the earliest discovered and most well understood ECF sigma factors is CarQ of the Gramnegative organism Myxococcus xanthus. CarQ is one of approximately 45 ECF sigma factors in
the M. xanthus genome and is responsible for carotenoid biosynthesis (Galbis-Martinez, GalbisMartinez, Murillo, & Fontes, 2008). Carotenoids are pigments that are made in response to light
and these compounds protect the organism from reactive oxygen species (ROS) produced by
light. The Bacillus subtilis genome encodes seven ECF sigma factors, with σW and σM being two
of the best characterized in Gram-positive bacteria. It has been demonstrated that σW controls the
expression of a large regulon that is made up of genes required for maintaining cell wall stability,
especially following exposure to cell wall targeting antibiotics (Butcher & Helmann, 2006), (Cao
et al., 2002), (Cao, Moore, & Helmann, 2005). In addition, there is evidence to suggest that σW
controls the expression of genes that are involved in the biosynthesis and secretion of
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bacteriocins (Butcher & Helmann, 2006), (Cao et al., 2002). The ECF sigma factor σM of B.
subtilis has been shown to be involved in responding to cell wall targeting antibiotics, which
include vancomycin, phosphomycin, and bacitracin, heat shock, acid shock, ethanol exposure,
oxidative stress, and osmotic pressure (Cao et al., 2002). B. subtilis also encodes a number of
other ECF-sigma factors, including σV. In regards to this element, although it is not well
characterized, it has been shown to be involved in the response to lysozyme (Guariglia-Oropeza
& Helmann, 2011) . Indeed, it is thought that σV is the major ECF sigma factor responsible for
sensing and responding to lysozyme stress in B. subtilis, as a sigV mutant and a mutant lacking
all seven ECF sigma factors demonstrated the same sensitivity to lysozyme (Guariglia-Oropeza
& Helmann, 2011), (Ho, Hastie, Intile, & Ellermeier, 2011). While the regulon of this ECF
sigma factor remains unclear, it is hypothesized that the resistance to lysozyme is mediated
through σV dependent control of genes that are involved in cell wall biosynthesis, such as oatA, a
peptidoglycan O-acytal transferase, the dltABCDE operon, which encodes enzymes that are
involved in teichoic acid D-alanylation; and pbpX a transpeptidase (Guariglia-Oropeza &
Helmann, 2011), (Ho et al., 2011).

Indeed, in the Gram-positive nosocomial pathogen

Enterococcus faecalis, σV, the only identified ECF sigma factor in this organism to date, was
also found to contribute to resistance to lysozyme (Ahmed et al., 2010); however, it does not
appear to be through σV mediated control of oat or the dltABCDE operon (Ahmed et al., 2010).
In addition to contributing to the resistance of E. faecalis to lysozyme, σV is also responsible for
contributing to survival following heat shock, acid shock, and treatment with ethanol (Benachour
et al., 2005). The non-pathogenic, high G+C Gram-positive organism Corynebacterium
glutamicum encodes five ECF sigma factors, with the best characterized being σH . In this
organism, σH is responsible for sensing and responding to heat and oxidative stress, and either
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directly or indirectly controls the expression of 65 genes, including four alternative sigma factors
and a number of stress response regulators (Patek & Nesvera, 2011).
ECF Sigma Factors and their Role in Pathogenesis. In addition to the growing number of
ECF sigma factors, their role in virulence is become increasingly apparent. The role of ECF
sigma factors in virulence The highly conserved ECF sigma factor σE is not only important in
bacterial physiology but also in its ability to facilitate infection. In uropathogenic E. coli, degS
encodes an inner membrane protease that is responsible for cleaving the anti-σE factor, RseA.
Mutants lacking the gene degS were attenuated in its ability to cause infection in a murine model
of urinary tract infection, suggesting the importance of σE in the virulence response of
uropathogenic E. coli (Redford, Roesch, & Welch, 2003; Redford & Welch, 2006). In addition,
the ability of S. typhimurium to cause infection is also dependent upon the ECF sigma factor σE.
Humphreys et. al. demonstrated that cells lacking σE were attenuated in virulence using a murine
model of infection (Humphreys et al., 1999). In addition, without σE, cells are less able to
survive within human derived macrophages and epithelial cells post phagocytosis, when
compared to the wild-type S. typhimurium strain (Humphreys et al., 1999). The M. tuberculosis
genome encodes ten ECF sigma factors, seven of which are either involved in, or predicted to be
involved in, virulence, with the most important being σE. Indeed, several studies have
demonstrated that the pathogenesis of M. tuberculosis is depended upon σE. (Abdul-Majid et al.,
2008), (Agarwal, Woolwine, Tyagi, & Bishai, 2007), (Ando, Yoshimatsu, Ko, Converse, &
Bishai, 2003), (Calamita et al., 2005), (Cardona et al., 2012), (Graham & Clark-Curtiss, 1999),
(Karls, Guarner, McMurray, Birkness, & Quinn, 2006), (Kaushal et al., 2002), (Riccardo
Manganelli & Provvedi, 2009; R. Manganelli et al., 2001), (S. Park & Imlay, 2003), (Raman et
al., 2006; Raman et al., 2001), (Sun et al., 2004).
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Schnappinger et. al. compared the

transcriptomes of M. tuberculosis grown under standard laboratory conditions and to those
isolated from murine macrophages after phagocytosis, and revealed that transcription of the ECF
sigma factor σE was among the first genes to be upregulated (Schnappinger et al., 2003). In
addition, it has also been previously described that expression of σE is strongly induced upon
phagocytosis by human macrophages, suggesting a role in virulence (Graham & Clark-Curtiss,
1999; R. Manganelli et al., 2004). Further to this, a number of studies have demonstrated that a
sigE null strain (the gene that encodes σE) of M. tuberculosis was not able to survive after
phagocytosis by THP-1 derived macrophages, murine-like macrophages, and monocyte derived
dendritic cells ((Casonato, Provvedi, Dainese, Palu, & Manganelli, 2014; Giacomini et al., 2006)
(R. Manganelli et al., 2001). Additionally, Ando et. al. and Manganelli et. al. demonstrated in a
murine model of lung infection, a sigE null strain was significantly attenuated in virulence when
compared to the wild-type (Ando et al., 2003), (R. Manganelli et al., 2004). Strikingly, several
studies have documented that a live attenuated vaccine made with an inactivated sigE, either by
insertion of an antibiotic resistance cassette, or deletion, led to better immunogenicity than the
current available BCG vaccine derived from M. bovis (Casonato et al., 2014), Hernandez
(Hernandez Pando, Aguilar, Smith, & Manganelli, 2010). Another ECF sigma factor in M.
tuberculosis that has been shown to be important in virulence is σC. Sun et. al. has been
demonstrated that the lethality of M. tuberculosis is also dependent on the ECF sigma factor σC
in a macrophage model of tuberculosis (Sun et al., 2004). Further to this, Sun et. al. also
performed a microarray to determine the regulon of σC

and found that the expression of

virulence determinants are decreased in a sigC null strain, which would explain the attenuation in
virulence demonstrated in a macrophage model of tuberculosis (Sun et al., 2004).

In P.

aeruginosa, AlgU, is also important in pathogenesis, especially in cystic fibrosis (McFarland &
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Stocker) patients (Govan & Harris, 1986), (Ogle, Janda, Woods, & Vasil, 1987). AlgU is
responsible for controlling production of alginate, which is the mucoid covering that protects this
bacterium in the lungs, and helps mediate infection (Govan & Harris, 1986), (Ogle et al., 1987)
by preventing phagocytosis and facilitating adherence (Marcus & Baker, 1985), (Ramphal &
Pier, 1985), (Schwarzmann & Boring, 1971),. In addition, it has also been demonstrated that
ECF sigma factors play a significant role in the uptake of iron, so much so that they form a
subgroup of ECF sigma factors known as iron starvation (IS) ECF sigma factors (Leoni, Ciervo,
Orsi, & Visca, 1996), (Visca, Leoni, Wilson, & Lamont, 2002). This is highlighted in P.
aeruginosa by the fact that of the 20 hypothesized ECF sigma factors encoded in the genome, 14
are thought to be involved in siderophore uptake (Banin, Vasil, & Greenberg, 2005), (Beare, For,
Martin, & Lamont, 2003), (Leoni, Orsi, de Lorenzo, & Visca, 2000), (Llamas et al., 2008;
Llamas et al., 2006), (Ochsner, Johnson, Lamont, Cunliffe, & Vasil, 1996), (Visca, Imperi, &
Lamont, 2007). It is well documented that the production of many P. aeruginosa virulence
factors is controlled by the concentration of iron available in the environment. One of the most
well studied ECF sigma factor involved in iron uptake is PvdS. This IS ECF sigma factor is
considered the main iron starvation sigma factor of P. aeruginosa, as it controls the expression of
genes involved in biosynthesis of pyroverdine, the primary siderophore, and its cognate receptor,
PvdA (Cunliffe, Merriman, & Lamont, 1995). Mutants lacking pvdS are known to be attenuated
in a rabbit model of infection, and are less able to form a biofilm than parental strains (Banin et
al., 2005), (Hunt, Peng, Loubens, & Storey, 2002), (Visca et al., 2007), (Xiong, Vasil, Johnson,
Ochsner, & Bayer, 2000). This attenuation of virulence has been linked to PvdS mediatedcontrol of transcription for at least 26 operons or genes (Cunliffe et al., 1995), (Ochsner et al.,
1996; Ochsner, Wilderman, Vasil, & Vasil, 2002), (Shigematsu et al., 2001).
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The information available on the role of ECF sigma factors in the pathogenesis of Gram-positive
bacteria is very limited, but is an area of growing interest. The genome of C. diptheriae, the
causative agent of diphtheria, harbors two ECF sigma factors, σE and σH. Diphtheria is a disease
that is as result of the production of a toxin (DT), which is under the control of an iron dependent
regulator, DtxR (Boyd, Oza, & Murphy, 1990). There is bioinformatics evidence to suggest that
expression of this major regulator is controlled by both σE and σH Oram, as promoter elements
that are characteristic of σE and σH from the closely related bacterium M. tuberculosis are located
upstream of dtxR. Accordingly, this suggests that these two sigma factors may contribute to the
pathogenesis of C. diphtheriae (Oram, Jacobson, & Holmes, 2006). Further to this, the Grampositive Firmicute Clostridium difficile encodes three ECF sigma factors CsfT, CsfU and CsfV,
all of which are thought to be involved in virulence (Ho & Ellermeier, 2011). Ho et. al. has
recently described that the inactivation of a proteases involved in the regulatory cascade leading
to CsfT, CsfU and CsfV upregulation renders this bacterium unable to colonize intestines in a
hamster model of infection (Ho & Ellermeier, 2011). Ahmed et. al. demonstrated in a murine
model of sepsis and a murine model of urinary tract infection that significantly less sigV mutant
was recovered from the organs when compared the wild-type, thus indicating σV plays a role in
the pathogenesis of E. faecalis (Ahmed et al., 2010). It is not, however, known exactly how σV
contributes to the virulence of E. faecalis as its regulon, and thus mechanistic role within the cell,
has yet to be elucidated (Ahmed et al., 2010).
Regulation of ECF Sigma Factors. ECF sigma factors are responsible for controlling the
expression of small regulons that are involved in responding to a particular environmental stress.
When bacterial cells are not experiencing stress, there must exist a mechanism of regulating
sigma factor activity so as to prevent transcription of unnecessary genes. Historically, a hallmark
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of the ECF sigma factor subfamily is that they are controlled by cognate anti-sigma factors that
are co-transcribed with the sigma factor (Helmann, 2002), (Staron et al., 2009). Anti-sigma
factors are usually membrane associated proteins consisting of at least one transmembrane
spanning region and interact with the ECF sigma factor through a conserved N-terminal domain,
while the C-terminal domain is located in the extracellular space sensing the environmental
surroundings (Helmann, 1999), (Hughes & Mathee, 1998), (Staron et al., 2009). ECF sigma
factor regulation by anti-sigma factors has been well studied regarding many σE homologues.
For example, σE of E. coli is regulated by its cognate anti-sigma factor RseA, both of which are
encoded within the same operon, along with two other genes (rseBC) that are involved in
regulating σE (Missiakas et al., 1997). RseA is an inner membrane protein whose N terminal
region interacts with σE, while the C terminal domain is located in the periplasm where it
interacts with RseB (Missiakas et al., 1997). It is hypothesized that RseB may sense misfolded
proteins and transmit this signal to RseA, leading to a conformation change and the release of σE
(Missiakas et al., 1997). In the context of RseC, it is thought to regulate via anti-anti-sigma
factor activity also, as it has been demonstrated that in the absence of rseC there is an
overexpression of σE (Missiakas et al., 1997).
The σE homologue in P. aeuriginosa, AlgU is also regulated by an anti-sigma facotor. AlgU is
the first gene in a five-gene operon that includes mucABCD, which are hypothesized to be
responsible for regulating the activity of AglU (Ramsey & Wozniak, 2005). The mucA gene
encodes the anti-sigma factor that is responsible for binding to AlgU and sequestering it (Ramsey
& Wozniak, 2005). Similar to RseB in E. coli, MucB is located in the periplasm and interacts
with the C terminal region of MucA, thereby negatively regulating AlgU activity (Rowen &
Deretic, 2000). While, the precise role of MucC has yet to be elucidated, there is evidence to
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suggest that it may interact with either MucA or MucB to negatively regulate AlgU. (Rowen &
Deretic, 2000). Finally, MucD is a homolog of DegS, and therefore may be involved in the
cleavage of the anti-sigma MucA (Rowen & Deretic, 2000).

In CF patients, it is the

disregulation of alginate biosynthesis that leads to the overproduction of the exopolysaccharide,
alginate (Damron & Goldberg, 2012), (Pulcrano, Iula, Raia, Rossano, & Catania, 2012). In P.
aeruginosa strains that colonize the lungs of CF patients, this environment leads to the
accumulation of point mutations in the genome. When these mutations occur in the mucA gene,
this leads to a non-functional MucA that cannot sequester AlgU, leaving AlgU to overexpress the
genes involved in biosynthesis of alginate (Damron & Goldberg, 2012), (Pulcrano et al., 2012).
In CF patients, alginate is considered a virulence factor as this mucoid layer results in an
inability of the host immune system to clear the infection. In addition, alginate overproduction
has also been linked to an increase in drug resistance because of the inability of drugs to
penetrate the thick mucoid layer (Pedersen, Hoiby, Espersen, & Koch, 1992).
With the continued characterization of ECF-sigma factors, and their cognate anti-sigma factors,
it is becoming increasingly apparent that the latter are not always transmembrane proteins. The
ECF sigma factor, σR of S. coelicolor is responsible for responding to oxidative stress in the
cytoplasm of this bacterium (M. S. B. Paget, 1998). σR is regulated by its anti-sigma factor
RsrA, which is a cytoplasmic protein, and, upon oxidative stress, will undergo a conformational
change that results in the release of σR (Bae, Park, Hahn, Kim, & Roe, 2004), (W. Li et al., 2003;
W. Li et al., 2002), (M. S. Paget et al., 2001), (Zdanowski et al., 2006). This conformational
change is mediated by the formation of intra-molecular disulfide bond formations that prevents
RsrA from binding and inhibiting the activity of σR (Kang et al., 1999). In addition, the σE
homolog of the photosynthetic bacteria Rhodobacter sphaeroides is responsible for responding
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to heme stress and blue light, which can lead to DNA damage (Braatsch, Moskvin, Klug, &
Gomelsky, 2004), (Newman, Falkowski, Schilke, Anthony, & Donohue, 1999). This sigma
factor is regulated by a soluble anti-sigma factor, ChrR (Newman et al., 1999). The exact
mechanism of σE-ChrR interaction is largely unknown; however, it has previously been
demonstrated that they form a heterodimer, and that ChrR requires zinc in order to inhibit σE
(Newman et al., 1999).
Recent research suggests that ECF sigma factors are not regulated by anti-sigma factors alone,
but that multiple mechanisms of controlling sigma factor activity exists. The ECF sigma factor
PvdS is regulated by the anti-sigma factor FpvR, but is also regulated at the level of transcription
by the iron regulator Fur (Leoni et al., 1996; Leoni et al., 2000),. In addition, CysB, which is the
master regulator of sulfur metabolism in P. aeruginosa, also controls expression of pvdS (Imperi,
Tiburzi, Fimia, & Visca, 2010). The Fur repressor is also involved in regulating the IS ECF
sigma factor PbrA of P. fluorescence, PfrI and PupI of P. putida and FecI of E. coli (Angerer,
Enz, Ochs, & Braun, 1995), (Koster, van Klompenburg, Bitter, Leong, & Weisbeek, 1994),
(Venturi, Ottevanger, Leong, & Weisbeek, 1993). Interestingly, there also exist ECF sigma
factors that are not regulated by anti-sigma factors at all. The first sigma factor to be classified
as an ECF sigma factor, σE of S. coelicolor, is not regulated at the post-translational level by an
anti-sigma factor, but at the level of transcription by the two-component system CseBC (M. S.
Paget, Leibovitz, & Buttner, 1999). This two-component system is transcribed in the same
operon as σE, and serves to determine the stability of the cell wall in S. coelicolor (M. S. Paget et
al., 1999).
There is also evidence that suggest that ECF sigma factors are regulated by novel mechanisms,
such as demonstrated with a subgroup of ECF sigma factors called ECF41. ECF41 is a group of
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ECF sigma factors that is uncharacterized, but widely distributed among prokaryotes. Members
of this group do not appear to be transcriptionally linked to anti-sigma factors, but are instead
flanked

by

highly

conserved

genes

that

encode

oxidoreductases,

epimerases,

or

carboymuconolacetones, suggesting that these genes may play a role in regulating sigma factor
activity (Wecke, Veith, Ehrenreich, & Mascher, 2006). In addition, these ECF sigma factors are
characterized as having an extended C-terminal domain that is thought to autoregulate their
activity (Wecke et al., 2006). Recent studies have explored these hypotheses and found that in B.
licheniformis the flanking genes do not appear to play a role in the regulation of the ECF sigma
factors.

However, Wecke et. al. present evidence that suggests the C-terminal domain is

involved in controlling sigma factor activity through an unknown mechanism (Wecke et al.,
2006). σJ of M. tuberculosis, another member of the ECF41 subgroup, is involved in the
response to hydrogen peroxide, and is flanked by a conserved oxioreductase that is hypothesized
to be involved in the regulation of this sigma factor by an unknown mechanism (Hu et al., 2004).
Sigma Factors of S. aureus. S. aureus is an extremely successful pathogen that regulates its
gene expression through the use of two component regulators, DNA-binding proteins and sigma
factors. Curiously, for such a successful pathogen, S. aureus oversees its complex network of
regulatory events with a limited number of sigma factors (Deora, Tseng, & Misra, 1997), ,
(Helmann, 2002), (Kill et al., 2005), (Kuroda et al., 2001), (Morikawa et al., 2003; Shaw et al.,
2008),. The primary σ factor, σA, is the essential housekeeping σ factor and is responsible for
transcription of genes for basic metabolic function (Deora & Misra, 1995, 1996). The alternative
sigma factor, σB, is closely related to σB of B. subtilis, and is the major stress response element in
the cell (Deora et al., 1997). σB has been shown to be involved in the virulence of S. aureus,
likely by aiding in regulating virulence determinant expression, as a sigB mutant was found to be
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attenuated in its ability to cause infection using a murine model of septic arthritis (Horsburgh et
al., 2002). sigB mutants have also been shown to have a decreased ability to form biofilms,
likely due to the increase in production of extracellular proteases (Atwood et al., 2015). σB of S.
aureus has also been shown to be involved in the response to alkaline, oxidative, and heat shock
(Deora et al., 1997), (Abdelnour, Arvidson, Bremell, Ryden, & Tarkowski, 1993), (Pane-Farre,
Jonas, Forstner, Engelmann, & Hecker, 2006).

The activity of σB is regulated post

translationally, similar to the σB homolog of B. subtilis, by a signal transduction mechanism
involving its anti-sigma factor, RsbW, and an anti-anti-sigma factor, RsbU (Senn et al., 2005).
The third σ factor of S. aureus, σH, shares homology to the Bacillus subtilis σH, and has a role in
the regulation of competence genes, and in the integration and excision of prophages (Morikawa
et al., 2003), (Tao, Wu, & Sun, 2010). The σH gene is regulated by two unique mechanisms:
The first is by a duplication rearrangement of the sigH gene with either nusG or rplK, two genes
transcribed immediately downstream (Peschel et al., 2012). This rearrangement results in a
chimeric gene that allows for the translation of a chimeric functional σH (Peschel et al., 2012).
The second mechanism is through post-transcriptional regulation via an upstream inverted repeat
that prevents translation of the σH protein (Peschel et al., 2012). These 13 base pair inverted
repeats form a stable stem-and-loop structure that sequesters the ribosomal binding site of sigH
transcript (Peschel et al., 2012). The fourth, and final, σ factor, σS, was recently discovered in
our laboratory and belongs to the ECF subfamily of σ factors (Shaw et al., 2008).
The Lone ECF Sigma Factor of S. aureus, σS. The sigS locus is conserved amongst the
staphylococci and consists of σS and two downstream genes. These genes are grouped together
amongst all sequenced S. aureus genomes, perhaps suggesting that they serve a common
function. As previously stated, many ECF sigma factors are co-transcribed with a cognate anti!
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sigma factor, which is commonly a transmembrane protein (Helmann, 1999) (Hughes & Mathee,
1998). The downstream gene, SAOUHSC_01898 (ecfX) does appear to be transcriptionally
linked to sigS; however, hydrophobicity plots indicate that there are no transmembrane regions
within its encoded protein. A second downstream gene, ecfY, which is divergent to sigS, is
predicted to have 2 transmembrane domains. Neither of these genes fit the classical anti-σ factor
model, which could indicate that a novel mechanism of regulation for sigS is in place. Previous
work performed in our lab demonstrates that a sigS mutant is more sensitive to lysis by Triton X100 than the wild-type. In addition, the sigS mutant is outcompeted by its parental strain in longterm growth experiments under standard laboratory conditions, and in the presence of chemical
stressors (hydrogen peroxide, diamide, hydrochloric acid, sodium hydroxide, EDTA, penicillin G
and ethanol). Using a murine model of septic arthritis, it was found that sigS is required for full
virulence of S. aureus (Shaw et al., 2008). Transcriptional studies of sigS using a lacZ fusion
demonstrate no expression of this element in several strains of S. aureus under standard
laboratory conditions, other than in the highly mutated strain RN4220 (Miller et al., 2012). This
differential expression of sigS is not attributed to single nucleotide polymorphisms (SNPs) in the
promoter region of sigS, which is identical in all strains.

Our laboratory has previously

demonstrated that sigS expression can be induced in the strain 8325-4 in response to a number of
chemical stressors that include cell wall targeting antibiotics and DNA damaging agents. In
addition, our group also demonstrated that sigS expression is highly induced when S. aureus is
challenged by components of the immune system, and upon phagocytosis by murine
macrophage-like cells, RAW 264.7.
Project Aim. The regulation of gene expression is a fundamental property to all living systems
that allows them to adapt and respond to different environmental conditions. For pathogenic
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bacteria, it is important to coordinate virulence gene expression, which is orchestrated by a
variety of factors, including sigma factors. Previous transcriptional studies by our group have
demonstrated expression under standard conditions of sigS in the highly mutated strain RN4220,
while expression is not detectable in 8325-4, SH1000, Newman and USA300. The differential
expression of sigS amongst the different S. aureus strains would suggest a tight level of
regulation. Therefore, the aim of this research is to elucidate mechanisms that are involved in
the regulation of sigS. The sigS locus is conserved amongst the sequenced staphylococci and this
suggests that they serve a common function. Preliminary work in our lab has indicated that EcfX
may interact with σS, while ecfY may negative regulate this ECF sigma factor by a novel
mechanism.

Therefore, we aim to investigate the contribution EcfX and EcfY make to

expression of sigS. Finally, in a separate, unrelated line of investigation, we aim to tackle the
problem of limited antibacterial therapeutics for S. aureus infections by testing the efficacy of a
library of quinazoline derivatives. It has previously been demonstrated that quinazoline based
compounds are effective both in vivo and in vitro against a broad range of pathogens, including
E. coli, P. aeruginosa, Plasmodium spp and Leishmania spp making them an ideal drug
candidate. Collectively, the results of this study will further our understanding of the complex
regulatory network of S. aureus and elucidate novel mechanisms of ECF sigma factor regulation,
in addition to developing novel antimicrobial agents that are effective against this organism.
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CHAPTER TWO:
INVESTIGATING THE GENETIC REGULATION OF THE ECF SIGMA FACTOR σS
IN STAPHYLOCOCCUS AUREUS
Note To Reader.

These results have been previously published (Burda et. al., 2014) with the

permission of the publisher and the published manuscript can be found in Appendix 2.
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CHAPTER THREE:
A NOVEL ANTISENSE GOVERNED MECHANISM REGULATES σS PRODUCTION
IN STAPHYLOCOCCUS AUREUS
Abstract. Our group has previously identified an ECF sigma factor, σS that is involved in the
stress and virulence responses of S. aureus. In this study we explore the sigS locus, and find that
a downstream protein, EcfX, not only binds to σS, but is seemingly a positive activator of its
ECF-sigma factor activity. In addition, we observed through RNAseq analysis that the majority
of transcription in this region actually originates from a gene (ecfY) that is downstream and
divergent to sigS. We demonstrate that inactivation of ecfY, leads to a significant increase in sigS
and ecfX expression; alongside increased resistant to UV, H2O2, MMS, and ethidium bromide,
conditions which a sigS mutant is highly sensitive to. Our studies also revealed that an ecfY null
strain is better able to survive intracellularly following phagocytosis and demonstrates increased
survival in whole-human blood, while a sigS mutant is more sensitive when challenged with
components of the immune system. Because the ecfY null strain is a sigS overexpressing strain,
we investigated the σS regulon using RNAseq analysis and identified genes under its control that
are involved in virulence, DNA damage and repair, amino acid starvation and nucleotide
biosynthesis.

Collectively, we demonstrate that the ECF-sigma factor in S. aureus, σS, is

regulated via unique methods: positively thought the apparent need for an activator protein, and
negatively via RNA-RNA interaction. We contend that this adds unique knowledge, not only to
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our understanding of S. aureus regulatory circuits, but also to alternative sigma factor biology in
general.
Introduction. The regulation of gene expression is a fundamental property of all living systems
that allows them to adapt and respond to different environmental conditions. Bacteria are
constantly faced with ever-changing environments, and their ability to respond quickly to these is
vital for survival. In the context of pathogenic bacteria, it is important to coordinate virulence
factor expression, so as not to waste resources and energy transcribing genes involved in
pathogenesis when not inside the host. Such control is orchestrated by a variety of systems,
including two-component systems, quorum sensing systems and DNA binding proteins.
Regulation can occur at the level of transcription, translation and post-translation, with the
primary point being at the level of transcription. In bacteria, transcription is mediated by the
multi-subunit enzyme RNA polymerase (RNAP), which consists of two functional forms: coreRNAP and the holoenzyme. Core-RNAP is responsible for transcription elongation and consists
of two α subunits, and one each of ω, β, and β’ subunits (Gruber & Gross, 2003), (Ishihama,
2000). In order for the holoenzyme to initiation transcription, it must first associate with a sigma
factor (Burgess, 1969).

Sigma factors are essential in promoter recognition and promoter

melting; without them there would be no transcription. All bacteria have a primary sigma factor
usually designated σA that is responsible for the transcription of most genes, including those with
housekeeping functions (e.g. cell wall synthesis, central metabolism, the replication machinery
etc.).
In addition to the primary sigma factor, there also exist alternative sigma factors, which control
subsets of genes that are involved in specialized cellular functions and/or stress response (e.g.
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oxidative stress, heat shock, etc.) (Kazmierczak, Wiedmann, & Boor, 2005). Bacteria employ
multiple sigma factors to allow the cell opportunities to change gene expression based on
differences in promoter selectivity exerted by each sigma factor in response to specific
environmental stimuli. The largest and most diverse class of alternative sigma factors is the
extracytoplasmic function sigma factors (ECF), of which there are predicted to be an average of
six encoded per bacterial genome (Staron et al., 2009). ECF sigma factors are a subfamily of the
σ70 family of sigma factors, and typically respond to environmental stress, such as alkaline and
heat shock (Cao et al., 2002), (Hahne et al., 2010), (Jervis, Thackray, Houston, Horsburgh, &
Moir, 2007), (Potvin et al., 2008), (R. Manganelli et al., 2001), (Thackray & Moir, 2003);
however, recent evidence suggests that these sigma factors also respond to cytoplasmic stimuli
(Campbell et al., 2007), (Dufour et al., 2008), (Francez-Charlot et al., 2009), (Newton & Fahey,
2008), (M. S. B. Paget et al., 2001), (S. T. Park, Kang, & Husson, 2008).
A hallmark of ECF sigma factors is that they are typically regulated in a post-translational
manner, in which they are co-transcribed with a cognate anti-sigma factor that binds to, and
inhibits, the ability of the ECF sigma factor to associate with RNAP and initiate transcription
(Helmann, 1999), (Hughes & Mathee, 1998). Prototypically, anti-sigma factors contain at least
one transmembrane domain and interact with their cognate ECF sigma factor through a
conserved N-terminal region, while the C-terminal domain is located in the extracellular space,
sensing environmental surroundings (Helmann, 1999), (Hughes & Mathee, 1998), (Staron et al.,
2009). As the number of ECF sigma factors identified increases, however, it becomes apparent
that not all of them are regulated in this way. In recent years, a number of novel mechanisms for
controlling ECF sigma factor activity have been identified (Jordan, Junker, Helmann, &
Mascher, 2006), (Kang et al., 1999), (M. S. B. Paget et al., 2001), (W. Li et al., 2002), (Hong,
!

34!

Paget, & Buttner, 2002), (Staron et al., 2009). Contrary to the classical transmembrane bound
anti-sigma factor, recent studies reveal that soluble anti-sigma factors exist that are responsible
for sensing cytoplasmic stress (Campbell et al., 2007), (Dufour et al., 2008), (M. S. B. Paget et
al., 2001), (S. T. Park et al., 2008). For example, in Streptomyces coelicolor, the ECF sigma
factor σR is regulated by its cognate anti-sigma factor, RsrA (Kang et al., 1999), (M. S. B. Paget
et al., 2001),, which has no transmembrane domains. Instead, it resides in the cytoplasm where it
binds to σR and prevents it from initiating transcription (Kang et al., 1999), (W. Li et al., 2002),
(M. S. B. Paget et al., 2001),. When S. coelicolor experiences disulfide stress, RsrA forms an
intramolecular disulfide bond that leads to a conformational change, and the release of σR (Bae et
al., 2004), (W. Li et al., 2002), (M. S. B. Paget et al., 2001), (Zdanowski et al., 2006). In
addition, σE of S. coelicolor has no cognate anti-sigma factor, but is instead regulated at the level
of transcription by the two-component system CseBC in response to cell wall perturbation (Hong
et al., 2002).

Other studies have suggested that some ECF sigma factors, including σJ of

Mycobacterium tuberculosis, are flanked by conserved, uncharacterized genes that may act to
regulate sigma factor activity by as yet unidentified mechanisms (Staron et al., 2009), (Wecke et
al., 2006). Furthermore, there have been ECF sigma factors described that are not associated
with an anti-sigma factor at all, but rather encode an extended C-terminal tail that acts to regulate
sigma factor activity (Hu et al., 2004), (Staron et al., 2009).
With its complex pathogenic lifestyle, it would be unsurprising if the Staphylococcus aureus
genome encoded several ECF sigma factors, especially with the prominent role these
transcriptional regulators play in virulence; however, to date only one (σS) has been identified
(Shaw et al., 2008). Previous work by our group has demonstrated that purified σS is able to bind
to and direct transcription from its own promoter (Shaw et al., 2008). In addition, we have
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shown that a sigS mutant is more sensitive to lysis by Triton X-100, and is outcompeted in longterm growth experiments by the parent strain under both standard growth conditions and in the
presence of chemical stressors. Most importantly, perhaps, we have demonstrated that sigS is
required for full virulence in S. aureus using a murine model of septic arthritis (Shaw et al.,
2008).

At the level of transcription, it appears that sigS is not expressed under standard

conditions, except in the highly mutated strain, RN4220. We have shown sigS upregulation in
other strains using a number of chemical stressors, including those that elicit damage to DNA
and the cell wall (Miller et al., 2012).

Further to this, expression of sigS is seemingly

upregulated when challenged by components of the immune system, and during phagocytosis by
murine macrophage-like cells (Miller et al., 2012). From a genetic perspective, sigS is directly
regulated by CymR, the master regulator of cysteine biosynthesis in S. aureus, and KdpE, the
response regulator of the two-component system KdpDE, which mediates potassium uptake and
sensing cyclic-diAMP (Burda et al., 2014), (Corrigan & Gründling, 2013), (Soutourina, Dubrac,
Poupel, Msadek, & Martin-Verstraete, 2010; Soutourina et al., 2009), (Xue, You, Hong, Sun, &
Sun, 2011). However, to date, no anti-sigma factor for σS has been identified.
While exploring the operon architecture of the sigs locus by RNAseq analysis, we observed an
interesting phenomenon in which there is extended read through from the gene ecfY, which is
downstream and divergently transcribed. In this study we described the inactivation of ecfY, and
demonstrate that its long 3’ UTR has a strongly inhibitory effect on sigS expression.
Furthermore, the ecfY mutant has opposing phenotypes to a sigS mutant; in that it is more
resistant to DNA damaging agents and components of the innate system, which we hypothesize
is due to overexpression of sigS. Finally, we perform RNAseq analysis with the ecfY to gain
insight into the σS regulon. Collectively, we present evidence that the ECF sigma factor, σS, is
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regulated in a unique manner, whereby it is influenced at the post-transcriptional level by the
downstream gene ecfY.
Bacterial strains and growth conditions. S. aureus and E. coli strains, along with plasmids and
primers, are listed in Table 2. E. coli was grown in Lysogeny Broth (LB) at 37ºC with shaking
at 250 rpm. S. aureus was grown in Tryptic Soy Broth (TSB) at 37ºC with shaking at 250 rpm,
unless indicated otherwise. Synchronized cultures were obtained as previously described (Shaw
et al., 2008). When required, antibiotics were added at the following concentrations: ampicillin
100 µg ml-1, tetracycline 5 µg ml-1, erythromycin 5 µg ml-1, lincomycin 25 µg ml-1, rifampicin
1.5 µg ml-1, 0.6 µg ml-1 ciprofloxacin and chloramphenicol 10 µg ml-1.
Northern blot analysis. Synchronized cultures of relevant bacterial strains were grown in TSB
for 3 h.

Cell pellets were resuspended in 100 µl TE buffer, added to lysing matrix D (MP

Biomedical) and cells lysed using a Minibeadbeater (Biospec Products). RNA was extracted
using an RNeasy Plus Mini Kit according to the manufacturer’s protocol (Qiagen).

RNA

samples were then mixed at a 1:2 ratio with Gel Loading Buffer II (Life Technologies) and
incubated at 95°C for 5 minutes before being loaded on a 1.5% agarose gel containing 2.2 M
formaldehyde; which was subsequently run at 65 V for 180 minutes. The fractionated RNA
samples were then transferred to an uncharged nylon membrane by upward capillary transfer..
Following this, the RNA was covalently linked to the membrane by UV irradiation.

The

resulting membrane was then pre-hybridized in 10 ml ULTRAhyb Ultrasensitive Hybridization
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Table 2. Strains, plasmids and primers used in this study.
Strain,
primer, or
plasmid

Genotype or description

Reference

φ80 Δ(lacZ)M15 Δ(argF-lac)U169 endA1 recA1 hsdR17 (rK-mK+) deoR thi-1 supE44 gyrA96
relA1

Sambrook

BL21

(DE3)pLysS

Promega

S. aureus
RN4220

Restriction deficient transformation recipient

Lab
stocks
Kolar et
al

E. coli
DH5α

USA300
Hou

Sequenced USA300 HOU-MRSA isolate cured of pUSA300-HOU-MRSA

Plasmid
pMK4
pMALC2a

Shuttle vector
N-terminal Maltose Binding Protein tag expression vector

pET24d+

C-terminal 6XHis tag expression vector

Primers1
OL1115
OL1116
OL1184
OL1185
OL1366
OL1367
OL1471
OL1550
OL1551
OL1568
OL1569
OL1903
OL1904
OL2393
OL2394
OL2952
OL3362
OL3363
OL3366
OL3446
OL3447

1

ATGACCATGGTGCAAGACAATTCTACTAAATATC
ATGACTCGAGCTTCATTGAAAATACTATTTCGAAT
AGCCGACCTGAGAGGGTGA
TCTGGACCGTGTCTCAGTTCC
ACGTGCACCGATACAA
GGCTCATCAACTTCTAGC
TTTATGGTACCATTTCATTTTCCTGCTTTTTC
ATGGGATCCGGGATGATGGTAACAGTG
ATGGTCGACTTATTTATCATCATCATCTTTATAATCTTTCGAATTAAATTTAATTTC
CGATTACGCAAATGAATG
CAAGTAGTCATTCTCCAAG
ATGGAATTCTTGAAATTTAATGACGTATACAAC
TGCTCTAGACTAATTAAAATTATGTTGGCATTTACGC
TCGTATGTTGTGTGGAATTG
GTGCTGCAAGGCGATTAAG
GATGTCCGTTAAGCGTAAATGCCAAC
ATGATGGGATCCGTACTTCACTGACAACTATGCCG
ATGGTCGACGTGGTGGTGGTGGTGGTGTTTCGAATTAAATTTAATTTCTAAAAG
GGTAACAGGCTTATTTAAGTTAACGCTG
CGTTAAACTTAATAAGCCTGTTACC
GGGCTAATTACAAGTCTATCTG

Restriction Enzyme sites are underlined
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Sullivan
New
England
Biolabs
Novagen

Buffer (Ambion) at 42°C in a hybridization oven (UVP HB-1000) for 1 h. During this time,
probes specific for ecfY (OL3366) were end labeled with P32 using T4 polynucleotide kinase
(NEB), and any un-incorporated P32 removed using a nucleotide cleanup kit according to the
manufacturer’s protocol (Qiagen). The labeled probe was then denatured by heating to 95°C for
5 minutes, before being added directly to the pre-hybridization solution and incubated overnight
at 42°C. Membranes were washed three times in 10 ml of: 2X saline-sodium citrate (SSC)
buffer, 1X SSC and 0.5X SSC. The resulting membrane was then exposed to X-ray film for 7
days.
Introduction of ecfY transposon mutant into S. aureus USA300. An ecfY::bursa aurealis
insertion in S. aureus USA300 strain JE2 was acquired from the Nebraska Transposon Mutant
Library. This transposon insertion is 40 nucleotides from the end of the gene and oriented
antisense to the coding region of ecfY. The ecfY::bursa aurealis construction was introduced
into the USA300 Houston (Hou) wild-type strain via φ11 mediated transduction, as described by
us previously (C. N. Krute et al., 2015). Successful transduction was confirmed by PCR analysis
using primers OL1471, which is specific to the transposon, and OL1550, which is specific to
ecfY.
Construction of ecfY complement strains.

Two ecfY complementation constructs were

generated: one that contains the promoter and coding region of ecfY (using primers OL3362 and
OL3363) and one that contains the promoter, the coding region and a 1kb fragment that extend
3’ of ecfY and includes sigS and ecfX (using primers OL1550 and OL1551). These fragments
were then cloned into the Gram-positive shuttle vector, pMK4, (Sullivan, Yasbin, & Young,
1984), with the resulting plasmids transformed into chemically competent E. coli DH5α.
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Successful transformation was determined by PCR analysis using a combination of gene specific
primers (OL3362/OL3363 for ecfY alone or OL1550/OL1551 for ecfY and the extended 3’ UTR)
and primers specific to pMK4 (OL2393/OL2394).

Additionally, Sanger sequencing using

plasmid specific primers was performed to confirm fidelity of the construct. These plasmids
were then transformed into S. aureus RN4220 by electroporation and confirmed by PCR, again
using a combination of gene specific and plasmid specific primers.

Correct clones were

introduced into the USA300 Hou ecfY::bursa aurealis strain by φ11 mediated transduction and
confirmed by PCR.
Quantitative Real-Time PCR.

Quantitative real-time PCR was performed as previously

described using primers specific to sigS, ecfX, and ecfY (Burda et al., 2014), (Miller et al., 2012).
Expression of ecfX and ecfY was determined using primer pairs OL1366/OL1367 and
OL3446/OL3447, respectively. The 16S rRNA gene was used as a control, as previously
described (Koprivnjak et al., 2006).
DNA damage sensitivity assays. Sensitivity to DNA damaging agents were determined as
previously described (Miller et al., 2012). Briefly, exponentially growing cultures were washed
and resuspended in phosphate buffered saline (PBS) before the addition of DNA damaging
agents: 1.1 M H2O2, 25 mM MMS and 2 mg ml-1 ethidium bromide. Cultures were placed at
37°C with shaking and aliquots were removed at the time intervals specified. Samples were then
serial diluted and CFU ml-1 were determined alongside control samples that were removed prior
to exposure. Percent survival was determined by comparing the initial CFU ml-1 to final CFU
ml-1 from three independent experiments.

Statistical significance was determined using a

Student t test with a 5% confidence interval.
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UV radiation survival assay. UV radiation survival assays were performed as previously
described (Miller et al., 2012).
Purification of recombinant σS, EcfX and LAP. The coding region of ecfX was amplified by
PCR using primers OL1115 and OL1116. This fragment was then subjected to restriction
enzyme digest using NcoI and XhoI and cloned into a similarly digested pET24d+. The resulting
construct was then transformed into DH5α and confirmed by restriction enzyme digest. Any
clones that were correct were then verified by Sanger sequencing using a T7 promoter primer
and a T7 terminator primer that flanks the multiple cloning site of pET24d+. The resulting
plasmid was then transformed into E. coli BL21(DE3)pLysS. Recombinant LAP was generated
as previously described (Carroll et al., 2013). Expression of ecfX and pepZ (the gene encoding
LAP) was induced with the addition of 1 mM isopropyl-1-thio-β-Dgalactopyranoside (IPTG) to
exponentially growing 1 liter cultures (OD600 = 0.6), and allowed to incubate for 5 h at 37°C.
EcfX and LAP were then purified as previously described (Burda et al., 2014), (Carroll et al.,
2013). Following elution, purified proteins were dialyzed for 48 hours against dialysis buffer (50
mM NaH2PO4, 300 mM NaCl, pH 8.0), with purified proteins stored in dialysis buffer
supplemented with 10% glycerol at -20°C.
For σS, its coding region was amplified by PCR using primers OL1903 and OL1904, and ligated
into pMAL-C2a. This generates a hybrid of the malE gene of E. coli followed by the sigS coding
region, which, upon induction, generates a σS protein fused to the maltose binding protein
(MBP). The resulting construct was then transformed into DH5α and confirmed by restriction
enzyme digest. Any clones that were correct were then verified by Sanger sequencing using an
M13 forward and an M13 reverse primer that flanks the multiple cloning site of pMAL-C2a.
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The resulting plasmid was then transformed into competent BL21(DE3)pLysS, and the
expression of sigS was induced with 1 mM IPTG to exponentially growing 1 liter cultures
(OD600 = 0.6), and allowed to incubate for 5 h at 37°C.

Cells were then harvested by

centrifugation and resuspended in 25 ml of column buffer (20 mM Tris-HCl, 200 mM NaCl and
1 mM EDTA). Lysozyme was added at a concentration of 1 mg ml-1 and then incubated at 37°C
for 1 h, in order to lyse the cells. Following this, the sample was sonicated on ice for a total of 3
minutes and clarified by centrifugation at 9,000g for 15 minutes. The supernatant was diluted in
125 ml of column buffer, added to an amylose column and then washed with 12 column volumes
of column buffer. MBP-σS was eluted from the column in column buffer containing 10 mM
maltose. Following elution, the purified protein was dialyzed for 48 hours against a dialysis
buffer, with purified proteins stored in dialysis buffer supplemented with 10% glycerol at -20°C.
Protein pull down assay. In an effort determine if σS and EcfX interact we performed a pull
down assay using recombinant versions of each protein. Purified MBP-σS was applied to an
amylose column and incubated at room temperature for 20 minutes before being washed with 25
ml of column buffer. Following this, purified EcfX was added and allowed to incubate for 1 h at
room temperature. To reduce non-specific protein interaction, the column was then washed with
25 ml of wash buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole, pH 8.0) before
any remaining proteins were eluted with column buffer containing 10 mM maltose. Samples
were then run on an SDS-PAGE gel followed by western blot analysis using an anti-6X His
antibody (specific for the recombinant EcfX protein). In order to determine if the interaction of
σS and EcfX was specific, the pull down assay was repeated in an identical fashion, however
purified LAP (a leucine aminopeptidase unrelated to the σS system (Carroll et al., 2013)) was
used in place of EcfX, as a negative control.
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Macrophage survival assay. A macrophage survival assay was performed using RAW 264.7
cells as described by us previously (Miller et al., 2012).
RNAseq analysis. RNAseq analysis of the USA300 wild-type and the ecfY::bursa aurealis
strain, both grown in TSB for 3h, was performed as described by us previously (Christina N.
Krute et al., 2015; Weiss, Ibarra, Paoletti, Carroll, & Shaw, 2014).
Bioinformatic analysis to determine the conserved sigS gene cluster in the staphylococci. In
an attempt to provide insight into potential anti-sigma factors of σS, we first performed a
bioinformatics analysis to identify genes that cluster with its coding region in the staphylococci.
When one looks at the sigS locus in S. aureus and other staphylococcal species one notes that it
is always clustered together with the same gene upstream, and the same 2 genes downstream
(Figure 2). When one performs bioinformatic analyses on the proteins produced by these 4
genes (SAUSA300_1721, sigS, ecfX and ecfY), EcfX is the only protein to have detectable
homology other than σS. In the context of EcfX, it seemingly possesses sequence homology to
the master regulator of competence in B. subtilis, ComK (Table 3). Interestingly, these same
genes also clustered together in the closely related bacterium Macrococcus caseolyticus (Figure
2), although this is perhaps unsurprising as the former name of this organism was
Staphylococcus caseolyticus until 17 years ago (Kloos et al., 1998). Other than these organisms,
as suggested by us previously (Shaw et al., 2008), we were unable to find this collection of genes
clustered together in the genome of any other bacterial organism outside of the staphylococci.
!
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Figure 2. Genomic analysis of the sigS locus in the staphylococci and the closely related
organisms. A schematic representation of the genomic context of the sigS locus in selected
staphylococci species and M. caseolyticus. The genomic alignment was made using the
Integrated Microbial Genomes (IMG) website (http://img.jgi.doe.gov). The alignment was
generated using all of the available staphylococcal genomes in the IMG database(20 organisms).
The sigS locus consists of SAUSA300_1721, sigS, ecfX and ecfY, which are always clustered
together (denoted by black box). The sigS gene is indicated by the arrow and is highlighted red.!
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Table 3. Genes found within the conserved sigS cluster in the staphylococci.
Annotation
SAUSA300_1721
SAUSA300_1722
SAUSA300_1722.1*
SAUSA300_1723

Gene
sigS
ecfX
ecfY

Function
Conserved hypothetical protein
ECF sigma factor
Conserved hypothetical protein
Conserved hypothetical protein

*ecfX is annotated herein as SAUSA300_1722.1 because it is not contained within the original genome annotation
file for the USA300 strain.
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The cognate gene to sigS, ecfX, encodes a protein that enhances, rather than represses, σS
activity. It is not uncommon for ECF sigma factors to be co-transcribed with one or more
negative regulators (Helmann, 2002), (Missiakas & Raina, 1998). Given the 112bp spacing
between sigS and ecfX, and the lack of an obvious transcriptional terminator, it appears likely
that these two elements are transcriptionally linked to each other. Previous studies in our lab
using a sigS-lacZ fusion, have indicated that in the absence of ecfX there is none of the enhanced
sigS expression that would be expected if this gene encodes an anti-sigma factor, at least in strain
SH1000 (Shaw et al., 2008). Indeed, we observed no detectable expression of sigS in the ecfX
mutant after 1 week of incubation of plates containing X-Gal (Shaw et al., 2008). Therefore, we
decided to evaluate the expression of sigS in an ecfX mutant via qPCR in strain RN4220, as we
have previously demonstrated expression of sigS in this strain under standard conditions (Figure
3.A). Surprisingly, we observed a significant decrease (59.6 fold) in sigS expression in the ecfX
mutant. To corroborate these findings in other strains, we also evaluated the expression of sigS in
an ecfX mutant in the USA300 background. Upon analysis we also observed decreased
expression of sigS (Figure 3.A), collectively suggesting that EcfX is a positive regulator of sigS
expression.
Interestingly, during our analysis of the sigS loci we discovered that in the ancient
staphylococcal species S. carnosus, sigS and ecfX are actually annotated as a single gene,
encoding a single protein. This lead us to hypothesize that sigS and ecfX genes arose as a single
unit that has since diverged into two separate genes/proteins in other staphylococcal species, but
that may still function together. In order to determine if σS and EcfX in S. aureus interact we
performed a pull down assay using purified recombinant proteins. To do this, a recombinant σS
that is fused to the maltose binding protein (MBP) of E. coli was generated and applied to an
!
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Figure 3. EcfX is a positive activator of σS. (A) qPCR analysis of sigS expression in an ecfX
mutant compared to RN4220 and USA300 parental strains. RNA was extracted from cultures
grown in TSB for 3 h. Error bars are shown as ± SEM, *** = p < 0.001 and **** = p < 0.0001
using a Student’s t-test. (B) A protein pull down was performed using purified recombinant σS,
EcfX and LAP. In the + columns EcfX or LAP was incubated with σS, while in the – column
EcfX or LAP was incubated in the presence of amylose resin alone. These samples were then
run on an SDS PAGE gel and subjected to western blot analysis using an anti-6X His antibody,
which is specific for EcfX and LAP. The first lane contains purified MBP-σS, whilst the last two
columns contain purified EcfX and LAP.
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amylose column. This approach allowed us to anchor σS to the column as a result of the Nterminal MBP tag. The column was then washed, before the addition of recombinant EcfX-His6.
The protein complex was then washed, eluted and run on an SDS-PAGE gel; followed by
subsequent Western blot analysis using an antibody specific to the hexahistidine tag (Figure
3.B). In so doing we observed that when σS was incubated with EcfX a band was visualized at
approximately 15 kDa (the EcfX + column in Figure 3.B), which is the molecular weight of
EcfX. This interaction is specific to the σS protein because we did not observe a band when
EcfX was incubated with the amylose resin alone (e.g. in the absence of σS, denoted as the –
column in Figure 3.B). In order to determine if the σS-EcfX interaction was specific, and not the
result of promiscuous binding, we repeated these analyses using purified LAP (also bearing a Cterminal hexahistidine tag) in place of EcfX. Importantly, when this pairing was tested we
observed no band in either lane with or without σS, indicating that the interaction of this ECFsigma factor is specific to EcfX.
Exploring the architecture of the sigS operon using RNAseq. When analyzing RNAseq data
previously generated in our laboratory for wild-type S. aureus (Weiss, Ibarra, Paoletti, Carroll, &
Shaw, 2014), we noted something unusual about the sigS locus. Specifically, we found that
almost all transcripts in this sigS-ecfX region appears to originate from extended read through of
ecfY, which is encoded in the opposite orientation to sigS and ecfX (Figure 4.A). This would
suggest that the low expression of sigS and ecfX observed under standard laboratory conditions
might be explained by read through from the ecfY transcript. In order to explore this further, we
first set out to confirm the overly large ecfY transcript size predicted by RNAseq, using northern
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blot analysis. This was performed on RNA extracted from the USA300 wild-type and a probe
that is specific to ecfY (Figure 4.B). If the ecfY transcript does indeed have the RNAseq
predicted large 3’ UTR, then the size of the band would be approximately 1.5 kilobases (kb);
however, if the transcript only contains the ecfY gene without a 3’ UTR, then there would be a
band visible at 450 bp. Upon analysis, we observed a band of 1.5 kb, which would indicate that
the ecfY transcript continues beyond its transcriptional stop codon, and reads in to ecfX and sigS
(in an antisense fashion). This raises the possibility that the sigS-ecfX locus is subject to posttranscriptional regulation resulting from the divergent partner gene, ecfY. Such an observation
represents a novel form of ECF-sigma factor based regulation, and begins to explain the very low
levels of sigS expression/synthesis in S. aureus cells.
A mutation in ecfY leads to increased expression of sigS and ecfX. Based on the RNAseq and
northern blot data presented above, we hypothesized that in the absence of ecfY, we should
observe an increase in sigS and ecfX expression under standard conditions. Whilst exploring the
NTML web viewer, we noted a mutant was present in this collection where a transposon has
inserted 40 bp from the stop codon of ecfY (and thus 400 bp from the start codon). Because of the
close proximity of the bursa aurealis transposon insertion to the end of the gene, we
hypothesized that this insertion would perhaps truncate the EcfY protein, and/or eliminate the
long 3’ UTR. To explore these contentions, we first determined the orientation of the transposon
relative to ecfY using a combination of gene and transposon specific primers (OL1471/1550 and
OL1471/1551, Table 2). We found that the transposon had inserted into ecfY on the forward
strand, while ecfY is encoded on the reverse strand, thus indicating that transcription from the
transposon would run antisense to the ecfY transcript. In order to determine if the ecfY transcript
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Figure 4. Analysis of the sigS operon using RNAseq. (A) The architecture of the sigS operon
as studied by RNAseq analysis in the USA300 wild-type strain. The red reads indicate
transcription from the negative strand, while green reads indicate transcription from the positive
strand. (B) Northern blot analysis of the ecfY transcript in the USA300 wild-type (WT) and the
ecfY transposon mutant strain. (C) Schematic representation of complementation constructs used
in this study, relative to panel A. The ecfY-S construct includes only the coding region for ecfY,
while the ecfY-L complement includes the coding region and the extended 3’ UTR.
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was affected by this insertion, we next repeated our northern blot analysis using the transposon
mutant (Figure 4.B). Importantly, using our ecfY specific probe, we did not observe any
transcript in the transposon mutant strain relative to the wild-type. As such, this would suggest
that insertion of the transposon in an anti-sense orientation at the 3’ end of the ecfY gene
effectively generates an ecfY knock-down strain.
Given that the long ecfY 3’ UTR is absent (along with the rest of the ecfY transcript) in the
transposon mutant, we next analyzed transcription of sigS and ecfX in the wild-type and mutant
strain. In so doing we observed a remarkable 13.4 –fold increase in sigS expression, and a 6.4 –
fold increase in ecfX expression, in the ecfY knock-down strain, relative to the parent (Figure 5).
This suggests that our hypothesis regarding the long 3’ ecfY UTR negatively impacting the
expression of sigS and ecfX is indeed true. However, as the ecfY coding region is also absent in
the transposon mutant, it is equally possible that a loss of EcfY protein results in this outcome.
Indeed, EcfY is predicted to be a membrane protein (Figure 6), and would therefore be an
obvious candidate to serve as a σS anti-sigma factor, apart from the fact it is not transcriptionally
linked to sigS, as is traditional for such regulators (Helmann, 1999), (Hughes & Mathee, 1998).
Nevertheless, this possibility could not thus far be excluded, and therefore our next approach was
to complement the transposon mutant with two different fragments of the ecfY coding region: the
first contained only the coding region of ecfY alone (ecfY-S), whilst the second contained the ecfY
coding region along with the 3’ UTR extension (ecfY-L). The rationale for this approach was that
if the ecfY-S complement successfully eliminated overexpression of sigS and ecfX in the ecfY
transposon mutant, then this would suggest the effect is mediated by the EcfY protein; putatively
as a classical anti-sigma factor. If, however, only the ecfY-L complement was able to abrogate
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Figure 5. Transcriptional profiling of sigS and ecfX in an ecfY null strain. qPCR analysis of
sigS (A) and ecfX (B) expression in the USA300 wild-type, ecfY null mutant strain, or the ecfY
null strain complemented with either the ecfY-S or ecfY-L (see text for explanation). RNA was
extracted from cultures grown in TSB for 3h. Error bars are shown as ± SEM, * = p < 0.05 **, =
p < 0.01 and *** = p < 0.001 using a Student’s t-test.
!
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Figure 6. Hydrophobicity plot of the EcfY protein in S. aureus. A SOSUI topology map of
the EcfY amino acid sequence indicates that this protein seemingly has two transmembrane
domains.
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the enhanced expression of sigS and ecfX in the transposon mutant strain, then this would
suggest the affect is mediated by a post-transcriptional, antisense RNA based mechanism.
Accordingly, we next repeated the qPCR analysis of sigS and ecfX expression using these two
complementing constructs, alongside the wild-type and transposon mutant strain. In so doing, we
found that the
ecfY-S complement alone did not reduce sigS and ecfX expression back to that of the wild-type,
but instead mirrored the ecfY transposon mutant (Figure 5).

Indeed, only when we

complemented with the ecfY-L construct did we successfully reduce sigS and ecfX expression
back down to wild-type levels. These results indicate that it is the ecfY transcript (and not the
resulting EcfY protein) that negatively affects sigS and ecfX expression, seemingly through
RNA-RNA based interaction, mediated by the long 3’ UTR of ecfY.
ecfY and sigS mutants have opposing phenotypes in their resistance to DNA damage. Given
that we have demonstrated sigS overexpression in a strain lacking ecfY, we hypothesized that
sigS and ecfY mutants may have opposing phenotypes when exposed to DNA damaging agents.
The reason for this is that, in previous studies by our group, we have demonstrated that sigS
expression is induced in the presence of DNA damaging agents (Miller et al., 2012), and that
sigS mutants are highly sensitive to the DNA damaging agents MMS, ethidium bromide, H2O2
and UV irradiation (Miller et al., 2012). To test this notion, we exposed the wild-type and ecfY
knock-down strain to 25 mM MMS for 30 minutes, and found that 24.1% of the transposon
mutant cells survived relative to the initial inoculum, yet only 6.3% of wild-type cells were
recovered (Figure 7.A). Conversely, we recovered 2.7% of the sigS mutant, validating our
hypothesis regarding the protective effects of sigS overexpression in the ecfY mutant.
!
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Figure 7. ecfY and sigS mutants have opposing phenotypes in their resistance to DNA
damage. The USA300 wild-type, ecfY null strain, the sigS mutant, and the ecfY null strain
complemented with either ecfY-S or ecfY-L (see text for explanation) were analyzed for viability
in the presence of various DNA damaging-inducing stressors. Shown are data from exposures to
25 mM MMS for 30 mins (A), 2 mg ml-1 Ethidium Bromide for 30 mins (B), 1.1 M H2O2 for 5
mins (C), and 4000 µJ per cm2 of UV (D). CFU counts were determined both pre-and postexposure and the percent recovery was determined. Error bars are shown as ± SEM, * = p < 0.05,
** = p < 0.01, and *** = p < 0.001 using a Student’s t-test. Significance for all strains was
determined relative to the wild-type strain (WT).
!
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Importantly, only the ecfY-L complementation construct restored the ecfY mutant to wild-type
levels of survival, indicating the effect is mediated by sigS overexpression, rather than any loss
of ecfY/EcfY. We next evaluated the ability of this same set of strains to survive exposure to
ethidium bromide (Figure 7.B). After 30 minutes incubation with 2 mg ml-1 ethidium bromide,
we observed a 41.3% recovery of the wild-type when compared to the initial inoculum, while we
recovered 99.5% of the ecfY null strain, which is a 2.4 fold increase in survival. Again in
contrast, we observed 14.4% survival of the sigS mutant relative to the initial inoculum, which
was a 2.8 fold decrease when compared to the wild-type. As we observed with our MMS
survival assay, we were able to complement our results to wild-type levels with the ecfY-L
complement strain but not ecfY-S. Similar findings were also determined for the oxidizing agent
H2O2 (Figure 7.C), as well as upon exposure to UV light (Figure 7.D), thus collectively
confirming sigS overexpression in an ecfY mutant is protective to cells undergoing DNA damage
stress.
An ecfY null strain is better able to survive exposure to components of the innate immune
response. We have previously observed that sigS is required for survival when exposed to
components of the innate immune response (Miller et al., 2012), (Shaw et al., 2008).
Accordingly, we set out to determine the impact of ecfY knock-down on the infectious capacity
of S. aureus. This was first accomplished by the use of a macrophage survival assay to evaluate
the ability of the wild-type and a ecfY null strain to survive following phagocytosis (Figure 8.A).
We determined that at 24h post-infection, the ecfY null strain displayed a 2.2 fold increase in
survival compared to the wild-type, whereas we observed a 2.7 fold decrease in viability of the
sigS mutant in the same circumstances. As with our previous complementation studies, the ecfYS construct was unable to reduce the ecfY mutant to wild-type survival levels, however the ecfY-L
!
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Figure 8. An ecfY mutant is better able to survive exposure to components of the innate
immune response. The USA300 wild-type (WT), ecfY knock-down strain, sigS mutant, and the
ecfY knock down strain complemented with either ecfY-S or ecfY-L (see text for explanation)
were assessed for viability 24h post phagocytosis by 264.7 RAW murine macrophage-like cells
(A), or 2h post-inoculation in whole human blood (B). CFU counts were determined both preand post-exposure and the percent recovery was determined. . Error bars are shown as ± SEM, *
= p < 0.05, ** = p < 0.01, and **** = p < 0.0001 using a Student’s t-test. Significance for all
strains was determined relative to the wild-type strain (WT).
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construct did. This again indicates that any survival advantage conferred on the ecfY mutant
results from sigS overexpression, rather than any consequence of ecfY/EcfY ablation. Further to
this, we have also previously demonstrated that a sigS mutant is more sensitive when exposed to
pooled whole human blood; therefore we also evaluated the ability of the ecfY transposon mutant
strain to survive in these same conditions. Exponentially growing cultures of the USA300 wildtype, alongside its ecfY and sigS mutants were separately inoculated into whole human blood and
incubated for 2h. Upon analysis, we recovered 6.7% of the ecfY null strain compared to the
initial inoculum, while we recovered only 1.4% of the wild-type, resulting in a 4.8 fold increase
in the ability of the ecfY null strain to survive relative to the parent (Figure 8.B). Conversely the
sigS mutant had only a 0.3% survival rate compared to the initial inoculum, which is a 4.6 fold
decrease compared to the parent. Our complementation studies again demonstrated that only the
ecfY-L construct restored ecfY survival to that of the parental level. Collectively, these works
again confirm the negative effects of the ecfY 3’ UTR on σS activity, and further support our
previous findings regarding the importance of σS for S. aureus disease causation.
Transcriptomic analysis of the ecfY knock-down strain. Because sigS is not expressed under
standard conditions, determining the regulon of this transcription factor using sigS-null strains
has thus far proven uninformative (our unpublished data). Additionally, our efforts to assess the
σS regulon using a sigS over-expressing strain have been thwarted because, despite correct
construction, no strain ever yielded sigS overexpression (as assessed by qPCR, data not shown).
Based on data presented herein, this latter finding is likely the result of the previously unknown
inhibitory effects of the ecfY 3’ UTR on sigS-ecfX expression. However, we show in the present
study that in the absence of ecfY, true sigS overexpression is possible. As such, we set out to
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exploit this effect, and assess the influence of a mutation in ecfY (and thus sigS overexpression)
on the transcriptome of S. aureus using RNAseq analysis (Figure 9).
In so doing, we found that the expression of 179 genes was up regulated and 308 genes were
down regulated by 2-fold or greater in the ecfY null strain compared to the parent. Ontologically,
these changes grouped into 21 different categories (Figure 10, Table 4, Table 5 and Table 6),
with the largest being those involved in amino acid biosynthesis. This is perhaps not unexpected,
as we have previously demonstrated that the expression of sigS is upregulated in amino acid
limiting media, and that expression of sigS is also influenced by the disruption of genes involved
in amino acid biosynthesis (Burda et al., 2014), (Miller et al., 2012). Further to this, we also
observed alterations in expression of genes that are involved in nucleotide biosynthesis, which
mirrors preliminary work by our group, suggesting that sigS may be involved in transcribing the
genes responsible for de novo assembly of nucleotides (Miller and Shaw, unpublished
observations). We also observed changes in expression of a number of different regulators,
including 3.08 and 3.63 fold decreases in cymR and lacR, respectively; which have both been
previously shown to negatively influence sigS expression (Burda et al., 2014), suggesting some
level of reciprocal regulation. We also identified changes in expression of genes that are
involved in the oxidative stress response, cell wall metabolism, DNA replication, recombination
and repair, and virulence, which we have already previously described to both influence sigS
expression and phenotypes of sigS mutants (Burda et al., 2014), (Miller et al., 2012).
Discussion. Bacteria with complex lifestyles or large genomes typically encode multiple ECF
sigma factors in order to rapidly bring about alterations in gene expression, and adaptation to
ever-changing environments. S. aureus is a formidable pathogen that has the ability to infect
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Figure 9. Genomic map of genes altered upon disruption of ecfY. The two outer most circles
represent genes annotated on the forward and reverse strands, respectively. The dark blue circle
represents expression values of genes in the wild-type, while the red inner most circle represents
the expression of genes in the ecfY transposon mutant strain. The circle in between the red and
the dark blue depicts a heat map of changes in expression between the two strains.
!
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Figure 10. Transcriptomic profiling of ecfY disruption using RNAseq analysis. Ontological
grouping of genes altered in expression upon disruption of ecfY, as compared to the parental
strain. RNA was extracted after 3h growth for both wild-type and mutant. Shown are those genes
found to be significantly altered in expression at 2-fold or greater.
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Table 4. Ontology groupings of genes whose expression is influenced by ecfY disruption.
Ontology
Metabolism
Protein Biosynthesis
Unknown Function
Transport
Nucleotide Biosynthesis
Amino Acid Biosynthesis
Virulence Associated
Stress Response
Regulator
Membrane Protein
Cofactor Biosynthesis
DNA Replication,
Recombination and Repair
Phage Protein
Protease
Cell Division
Cell Surface Associated
Antibiotic Resistance
Cell Wall Metabolism
Transcription
Acetyltransferases
Lipoprotein
Total

!
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Up regulated
20
34
15
20
10
7
7
5
14
15
2

Down regulated
55
20
35
27
25
25
23
23
13
9
14

Total
75
54
50
47
35
32
30
28
27
24
16

7

6

13

8
0
4
4
2
1
3
1
0
179

4
11
5
2
3
4
1
2
1
308

12
11
9
6
5
5
4
3
1
487
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Table 5. Genes with decreased expression upon ecfY disruption.
Annotation

Gene

Function

Fold Change

Acetyltransferases
SAUSA300_2468

Acetyltransferase, GNAT family

-3.02

SAUSA300_1070

Acetyltransferase, GNAT family

-2.57

Amino Acid Biosynthesis
SAUSA300_1976

Succinyl-diaminopimelate desuccinylase

-5.04

Glycine cleavage system H protein

-4.80

Threonine aldolase

-3.65

Choline dehydrogenase

-3.57

SAUSA300_0360

Cystathionine gamma-synthase

-3.22

SAUSA300_0451

GNAT acetyltransferase

-2.91

SAUSA300_0325

gcvH

SAUSA300_1214
SAUSA300_2545

betA

SAUSA300_0445

gltB

Glutamate synthetase, large subunit

-2.86

SAUSA300_1049

murI

Glutamate racemase

-2.83

ABC-type amino acid transport system, permease component

-2.68

SAUSA300_2358
SAUSA300_2404

gltB

Glutamate synthase domain 2

-2.61

SAUSA300_1452

proC

Pyrroline-5-carboxylate reductase

-2.59

SAUSA300_2359

Amino acid ABC transporter, amino acid-binding protein

-2.56

SAUSA300_1710

Lysophospholipase

-2.48

Cysteine synthase

-2.45

SAUSA300_0491

cysK

SAUSA300_1329

Amino acid permease

-2.40

SAUSA300_2546

betB

Glycine betaine aldehyde dehydrogenase

-2.35

SAUSA300_0722

murB

UDP-N-acetylenolpyruvoylglucosamine reductase

-2.34

Hypothetical protein

-2.33

SAUSA300_1560
SAUSA300_2251

Dehydrogenase

-2.29

SAUSA300_2281

hutG

Formimidoylglutamase

-2.19

SAUSA300_1139

sucD

-2.16

SAUSA300_0185

argJ

Succinyl-CoA synthetase, alpha-subunit
Bifunctional ornithine acetyltransferase/N-acetylglutamate synthase
protein

SAUSA300_2067

glyA

Serine hydroxymethyltransferase

-2.11

SAUSA300_0433

cysM

Cysteine synthase/cystathionine beta-synthase

-2.02

SAUSA300_0359

metC

Cystathionine beta-lyases/cystathionine gamma-synthases

-2.01

-2.15

Antibiotic Resistance
SAUSA300_2394

OmdA bacteriocin/AMP protection domain

-2.64

SAUSA300_1328

norB

Quinolone resistance protein

-2.57

SAUSA300_2396

pnbA

Para-nitrobenzyl esterase

-2.17

Cell Division
SAUSA300_0438

N-acetylmuramyl-l-alanine amidase

-5.21

SAUSA300_0361

sle1

Putative nucleoid occlusion protein

-3.56

SAUSA300_2353

Addiction System antitoxin (Txe/YoeB family)

-3.45

SAUSA300_1787

HIT family hydrolase.

-2.74

SAUSA300_2402

Addiction System antitoxin (Txe/YoeB family)

-2.29

Cell Surface Associated
SAUSA300_0548

!

sdrE

Surface Protein

-2.37
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Table 5 Continued
Annotation
SAUSA300_1370

Gene
ebpS

Function
Elastin-binding protein ebpS

Fold Change
-2.10

Cell Wall Metabolism
SAUSA300_2316

Acetyltransferase, GNAT family

-5.56

SAUSA300_2097

Putative NAD dependent epimerase / oxidoreductase

-4.95

LysM peptidoglycan binding domain

-3.15

Autolysin

-2.14

SAUSA300_0739
SAUSA300_0955

atl

Cofactor Biosynthesis
SAUSA300_2532

panD

Aspartate 1-decarboxylase

-4.99

SAUSA300_2225

moaC

Molybdenum cofactor biosynthesis protein C

-3.79

SAUSA300_2534

panB

3-methyl-2-oxobutanoate hydroxymethyltransferase

-3.78

SAUSA300_1893

nadE

NH(3)-dependent NAD(+) synthetase

-3.75

SAUSA300_0492

folP

Dihydropteroate synthase

-3.57

SAUSA300_1894

Nicotinate phosphoribosyltransferase

-3.24

SAUSA300_0551

GTP cyclohydrolase

-3.22

SAUSA300_0504

pdxS

Pyridoxal biosynthesis lyase

-2.70

SAUSA300_0381

nfrA

Flavin mononucletoide dependent NADPH oxidase

-2.53

SAUSA300_2344

sirB

Uroporphyrinogen III methylase SirB, putative

-2.44

Rhodanese-Like Domain Protein

-2.39

Pantoate-beta-alanine ligase

-2.39

SAUSA300_1451

Short chain dehydrogenase/reductase

-2.13

SAUSA300_1100

3-demethylubiquinone-9 3-methyltransferase

-2.00

SAUSA300_1703
SAUSA300_2533

panC

DNA Replication, Recombination and Repair
SAUSA300_0668

Weak MutS2 domain

-5.61

SAUSA300_2485

ada

Methylated-DNA--protein-cysteine methyltransferase

-4.08

SAUSA300_1362

hup

HU Histone Like Protein

-3.36

SAUSA300_0097

Superfamily I DNA and RNA helicases and helicase subunits

-2.76

SAUSA300_1573

Holliday junction resolvase-like protein

-2.51

Excinuclease ABC subunit C

-2.13

SAUSA300_1045

uvrC

Lipoprotein
SAUSA300_1440

Lipoprotein

-4.06

SAUSA300_0419

Staphylococcal tandem lipoprotein

-3.56

Putative lipoprotein

-2.43

SAUSA300_2403

Putative lipoprotein

-2.10

SAUSA300_0992

Putative cell-wall binding lipoprotein

-2.04

SAUSA300_0693

saeP

Membrane Protein
SAUSA300_1802

Membrane protein

-5.88

SAUSA300_0108

Myosin-cross-reactive antigen like family

-4.27

SAUSA300_0374

Putative membrane protein

-2.97

SAUSA300_1107

Membrane protein

-2.79

SAUSA300_2286

Membrane protein

-2.26

SAUSA300_2252

Membrane protein

-2.19
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Table 5 Continued
Annotation

Gene

Function

Fold Change

SAUSA300_0341

Membrane protein

-2.19

SAUSA300_2320

Membrane protein

-2.00
Metabolism

SAUSA300_0151

adhE

Alcohol dehydrogenase, iron-containing

-11.50

SAUSA300_0594

adh

Alcohol dehydrogenase/acetaldehyde reductase

-9.74

SAUSA300_1044

trx

Thioredoxin

-7.91

SAUSA300_2079

fba

Fructose-bisphosphate aldolase

-6.74

Haloacid dehalogenase-like hydrolase

-6.70

Respiratory nitrate reductase, alpha subunit

-6.69

SAUSA300_1874

Nonheme-containing ferritin

-6.17

SAUSA300_1725

Transaldolase

-6.15

SAUSA300_2475

Acyl-CoA thioester hydrolase, YbgC/YbaW family

-5.23

Nitrite reductase [NAD(P)H], large subunit

-4.74

Fructose-1,6-bisphosphate aldolase

-4.69

SAUSA300_0557
SAUSA300_2343

SAUSA300_2346

narG

nirB

SAUSA300_2540
SAUSA300_2492

Galactoside O-Acetyltransferase

-4.58

SAUSA300_1258

4-Oxalocrotonate tautomerase

-4.39

SAUSA300_1728

Aldo/keto reductase

-4.30

SAUSA300_0591

GNAT Acetyltransferase

-4.25

Formate acetyltransferase

-4.20

FAD/NAD(P)-binding Rossmann fold superfamily

-4.19

Phosphatidylinositol-specific phospholipase

-3.86

Acyl-CoA dehydrogenase

-3.86

SAUSA300_0220

gat

pflB

SAUSA300_0394
SAUSA300_0099

plc

SAUSA300_2236
SAUSA300_2537

L-lactate dehydrogenase 2

-3.77

SAUSA300_0556

6-phospho-3-hexuloisomerase

-3.59

SAUSA300_0129

2,3-butanediol dehydrogenase

-3.47

SAUSA300_2593

Flavin reductase/oxidoreductase

-3.45

SAUSA300_1125

ldh2

Acyl carrier protein

-3.16

SAUSA300_2473

Esterase/Lipase

-3.14

SAUSA300_2525

Fructosamine-3-kinase

-3.07

Triosephosphate isomerase

-3.07

SAUSA300_2146

Zn containing alcohol dehydrogenase

-3.03

SAUSA300_0789

Thioredoxin

-2.93

4,4′-diaponeurosporen-aldehyde dehydrogenase

-2.89

Medium-chain acyl-CoA synthetase

-2.85

Nitronate monooxygenase

-2.85

Chaperone

-2.84

SAUSA300_2416

Short chain dehydrogenase

-2.82

SAUSA300_1248

Fe-S cluster assembly scaffold protein

-2.71

SAUSA300_2260

Dual specificity inositol monophosphatase/NADP(H) phosphatase

-2.64

SAUSA300_2317

Quinone oxidoreductase of Zn-dependent oxidoreductase
Bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase/ 5,10methylene-tetrahydrofolate cyclohydrolase

-2.57

SAUSA300_0758

SAUSA300_1901

acpP

tpiA

aldH

SAUSA300_2542
SAUSA300_0825
SAUSA300_0536

SAUSA300_0965

!

hchA

folD
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SAUSA300_1804

Glucosamine-6-phosphate isomerase

-2.47

SAUSA300_0841

NADH dehydrogenase, FAD-containing subunit

-2.38

NAD(P)H-flavin oxidoreductase/nitroreductase

-2.32

SAUSA300_2267

Haloacid dehalogenase (HAD) subfamily IA

-2.29

SAUSA300_0177

Acyl/Butyrl-CoA dehydrogenases

-2.27

SAUSA300_2254

2-hydroxyacid dehydrogenase

-2.26

Sucrose-6-phosphate hydrolase

-2.25

Arylamine N-acetyltransferase

-2.25

Thioesterase superfamily

-2.21

Coenzyme A disulfide reductase

-2.20

SAUSA300_1081

Multi-copper polyphenol oxidoreductase laccase

-2.19

SAUSA300_0540

HAD hydrolase, family IIIA

-2.17

SAUSA300_0375

Phosphoglycerate mutase

-2.14

SAUSA300_2076

Aldehyde dehydrogenase family protein

-2.12

SAUSA300_2461

Ring-cleavage extradiol dioxygenase

-2.11

SAUSA300_0903

Thioredoxin or dithiol-disulfide isomerase

-2.09

4,4'-diaponeurosporenoate glycoslytransferase

-2.04

SAUSA300_2462

SAUSA300_1994

frp

scrB

SAUSA300_2631
SAUSA300_0847
SAUSA300_0873

SAUSA300_2500

cdr

crtQ

Nucleotide Biosynthesis
SAUSA300_2551

nrdD

SAUSA300_2548
SAUSA300_0747

-5.95

Metallo-beta-lactamase superfamily

-4.03

Thioredoxin reductase

-3.78

SAUSA300_2518

Alpha/beta hydrolase family

-3.76

SAUSA300_0307

5'-nucleotidase

-3.75

Anaerobic ribonucleotide reductase, small subunit

-3.65

SAUSA300_2580

Isochorismatase family of cystine hydrolases-protein

-3.28

SAUSA300_0147

5'-nucleotidase/2',3'-cyclic phosphodiesterase

-3.09

SAUSA300_2550

trxB

Anaerobic ribonucleotide reductase, large subunit

nrdG

SAUSA300_2439

galU

UTP--glucose-1-phosphate uridylyltransferase

-3.00

SAUSA300_0907

relQ

Putative (p)ppGpp synthase domain protein

-2.90

SAUSA300_0517

RNA methyltransferase

-2.82

SAUSA300_0025

UshA like protein

-2.79

SAUSA300_1050

Nucleoside triphosphate

-2.63

SAUSA300_0288

Hypothetical Protein

-2.61

Uridylate kinase

-2.57

Hypothetical Protein

-2.50

SAUSA300_1151

pyrH

SAUSA300_2080
SAUSA300_0141

deoB

Phosphopentomutase

-2.39

SAUSA300_2066

upp

Uracil phosphoribosyltransferase

-2.30

Ribonuclease III family protein

-2.21

Urease accesory protein

-2.17

SAUSA300_0516
SAUSA300_2243

ureG

SAUSA300_0459

tmk

Thymidylate kinase

-2.13

SAUSA300_2446

relP

Putative (p)ppGpp synthase domain protein

-2.10

Metallophosphoesterase

-2.08

SAUSA300_1181

!
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ureC

SAUSA300_0905

Function

Fold Change

Urease, alpha subunit

-2.07

Triphosphate tunnel metalloenzyme (TTM)-like superfamily

-2.02

Phage Proteins
SAUSA300_0815

ear

Ear Protein

-4.96

SAUSA300_1969

Phage transcriptional repressor

-3.95

SAUSA300_1861

Phage protein

-2.91

SAUSA300_0579

Phage protein

-2.50
Proteases

SAUSA300_0372
SAUSA300_2486

clpL

SAUSA300_0105

PepSY/YPEB domain

-4.71

Endopeptidase Clp ATP-binding regulatory subunit

-3.87

Putative amidohydrolases

-3.65

SAUSA300_2400

pepA2

Aminopeptidase

-3.57

SAUSA300_1674

htrA1

HtrA1 Serine Protease

-3.48

SAUSA300_0752

clpP

ClpP Protease

-2.94

SAUSA300_2087

hmrA

HMRA peptidase.

-2.85

SAUSA300_1460

pepT2

Aminopeptidase

-2.47

SAUSA300_1654

pepP1

Proline specific aminopeptidase

-2.30

SAUSA300_1691

pepA1

Aminopeptidase

-2.09

SAUSA300_1905

Predicted choloylglycine hydrolase

-2.01

Protein Biosynthesis
SAUSA300_1823

tRNA

-7.16

SAUSA300_0447

tRNA

-4.36

SAUSA300_1834

tRNA

-4.14

SAUSA300_0343

Acetyltransferase, GNAT family

-3.32

PrsA-like protein

-3.17

SAUSA300_0943

GNAT acetyltransferase

-3.10

SAUSA300_1813

tRNA

-3.09

SAUSA300_1909

Thioredoxin-type protein
rRNA large subunit methyltransferase, in the SPOUT methyltransferase
family

-2.89

tRNA

-2.72

tRNA

-2.72

Tryptophanyl-tRNA synthetase

-2.68

Lipoate-protein ligase A

-2.61

rpsA

30S ribosomal protein S1

-2.54

SAUSA300_0522

rplK

Ribosomal protein L11

-2.51

SAUSA300_2074

rpmE

50S ribosomal protein L31 type B

-2.37

Thioredoxin-type protein

-2.29

Translation elongation factor Ts

-2.27

Leucyl tRNA-synthetase

-2.19

Phenylalanyl-tRNA synthetase (Beta subunit)

-2.01

SAUSA300_0857

SAUSA300_0026

prsA2

rimH/orfX

SAUSA300_1830
SAUSA300_1833
SAUSA300_0897

trpS

SAUSA300_0930
SAUSA300_1365

SAUSA300_2474
SAUSA300_1150

tsf

SAUSA300_1704

leuS

SAUSA300_1688

Regulators

!
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SAUSA300_2347

nirR

Nitrite reductase transcriptional regulator

-4.40

SAUSA300_2156

lacR

Lactose operon repressor

-3.63

SAUSA300_1639

phoP

PhoP response regulator

-3.38

SAUSA300_1583

cymR

Cystine metabolism regulator

-3.09

LytR response regulator

-2.87

Sporulation regulatory protein

-2.79

XRE-family DNA Binding Protein

-2.76

NreB Histidine Kinase

-2.67

SAUSA300_0655

YebC/PmpR putative transcriptional regulator

-2.33

SAUSA300_0878

LysR Regulator

-2.27

SAUSA300_2625

PadR family transcriptional regulator

-2.19

Potassium transport regulator

-2.19

SirA-like protein

-2.18

SAUSA300_0255

lytR

SAUSA300_0475

spoVG

SAUSA300_0373
SAUSA300_2338

SAUSA300_0988

nreB

ktrA

SAUSA300_1997

Stress Response
SAUSA300_0234

hmp

SAUSA300_1652
SAUSA300_0859

Nitric oxide dioxygenase

-5.06

Universal stress protein

-4.68

NADH:flavin oxidoreductases

-4.28

Peroxiredoxin (PRX) family

-3.43

SAUSA300_1659

tpx

SAUSA300_0816

cbsD

CsbD-like superfamily general stress protein

-3.27

SAUSA300_0380

ahpC

Alkyl hydroperoxide reductase subunit C

-3.11

SAUSA300_1784

traP

Signal transduction protein

-3.03

SAUSA300_0786

Peroxiredoxin/organic hydroperoxide resistance protein

-2.86

SAUSA300_1582

CsbD superfamily

-2.75

SAUSA300_1788

Uncharacterized membrane protein

-2.67

Superoxide dismutase

-2.63

Disulphide isomerase

-2.61

Metal ion stress protein

-2.46

Glyoxalase family protein

-2.40

PfpI intracellular protease

-2.39

Putative mechanosensitive channel protein

-2.25

General stress protein 20U

-2.20

Putative arsenate reductase

-2.19

SAUSA300_1513

sodA

SAUSA300_1463
SAUSA300_0508

mcsA

SAUSA300_0338
SAUSA300_1856

pfpI

SAUSA300_0362
SAUSA300_2092

dps

SAUSA300_0790
SAUSA300_0135

Superoxide dismutase

-2.07

SAUSA300_0484

Ribosome-associated heat shock protein

-2.06

SAUSA300_2327

Pyridoxamine 5'-phosphate oxidase family protein

-2.05

SAUSA300_0486

S1 RNA Binding Domain Protein

-2.01

Heme peroxidase

-2.01

SAUSA300_0569

sodM

hemQ

Transcription
SAUSA300_1103

rpoZ

RNAP omega subunit

-4.30
Transport

SAUSA300_0173

!

Dipeptide/oligopeptide/nickel ABC transporter permease
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SAUSA300_2628

rarD

Transporter

-4.87

SAUSA300_2333

narK

Nitrite extrusion protein

-4.64

SAUSA300_0676

Divalent Anion:Na+ Symporter

-4.12

SAUSA300_2472

EamA family transporter

-3.85

SAUSA300_0176

ABC transporter, permease protein

-3.73

SAUSA300_0344

fepA

Iron-transport system

-3.61

SAUSA300_2479

cidA

Holin-like protein

-3.13

Putative uroporphyrin-III C-methyltransferase

-2.90

SAUSA300_0232
SAUSA300_0345

fepB

Iron-transport system

-2.88

SAUSA300_2557

nsaA

ABC transporter protein

-2.86

SAUSA300_0796

ABC-type transport system, ATPase component

-2.79

SAUSA300_0174

Nitrate sulfonate taurine bicarbonate transport system ATPase component

-2.78

Glycine betaine/carnitine/choline ABC transporter ATP-binding protein

-2.77

SAUSA300_0175

ABC transporter, substrate-binding protein

-2.63

SAUSA300_2399

ABC-type uncharacterized transport system, ATPase component

-2.63

SAUSA300_2627

Divalent Anion:Na+ Symporter

-2.60

SAUSA300_2552

Citrate transporter

-2.58

Iron compound ABC transporter, permease protein

-2.56

PTS system, IIBC component

-2.22

SAUSA300_2393

SAUSA300_0115

opuCA

sirC

SAUSA300_0236
SAUSA300_0824

corB

Magnesium and cobalty efflux protein

-2.20

SAUSA300_1676

sgtA

Monofunctional transglycosylase

-2.18

SAUSA300_2398

ABC-type uncharacterized transport system, permease component

-2.17

SAUSA300_0309

ABC transporter ATP-Binding protein

-2.14

SAUSA300_1998

Possible selenium or sulfur transporter

-2.10

SAUSA300_0382

Na+/dicarboxylate symporter

-2.10

Cell wall anchored hemoglobin binding protein

-2.02

SAUSA300_1029

isdA

Unknown Function
SAUSA300_0768

Unknown

-9.50

SAUSA300_1747

Unknown

-4.65

SAUSA300_0740

Unknown

-4.26

SAUSA300_0567

Unknown

-4.25

SAUSA300_1012

Unknown

-4.22

SAUSA300_1574

Unknown

-4.08

SAUSA300_0409

Unknown

-4.06

SAUSA300_0940

Unknown

-3.98

SAUSA300_2093

Unknown

-3.81

SAUSA300_2592

Unknown

-3.79

SAUSA300_2641

Unknown

-3.61

SAUSA300_0657

Unknown

-3.60

SAUSA300_2531

Unknown

-3.56

!
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SAUSA300_0842

Unknown

-3.13

SAUSA300_0294

Unknown

-2.96

SAUSA300_0460

Unknown

-2.90

SAUSA300_0421

Unknown

-2.68

SAUSA300_0793

Unknown

-2.60

SAUSA300_0339

Unknown

-2.45

SAUSA300_2005

Unknown

-2.43

SAUSA300_0383

Unknown

-2.38

SAUSA300_2068

Unknown

-2.30

SAUSA300_0041

Unknown

-2.27

Unknown

-2.26

SAUSA300_0602

Unknown

-2.25

SAUSA300_0767

Unknown

-2.24

SAUSA300_1439

Unknown

-2.23

SAUSA300_0931

Unknown

-2.18

SAUSA300_0287

Unknown

-2.12

SAUSA300_0035

Unknown

-2.11

SAUSA300_0595

Unknown

-2.05

SAUSA300_2544

Unknown

-2.05

SAUSA300_1898

Unknown

-2.04

SAUSA300_1240

Unknown

-2.03

SAUSA300_1665

Unknown

-2.02

SAUSA300_2053

ywpF

Virulence Associated
SAUSA300_0883

eapH2

Eap/Map protein

-19.72

SAUSA300_1382

lukS-PV

Panton-Valentine leukocidin, LukS-PV

-13.54

SAUSA300_1381

lukF-PV

Panton-Valentine leukocidin, LukF-PV

-12.17

SAUSA300_0951

sspA

V8 protease

-6.79

SAUSA300_1918

hlb

Truncated beta-hemolysin

-5.36

SAUSA300_2441

fnbpA

Fibronectin binding protein A

-4.95

SAUSA300_2572

aur

Zinc metalloproteinase aureolysin

-4.88

SAUSA300_0950

sspB

Staphopain B

-4.71

SAUSA300_1758

splA

Serine protease SplA

-4.58

SAUSA300_2435

SasG protein

-3.80

SAUSA300_2367

hlgB

Gamma-hemolysin component B

-3.53

SAUSA300_0285

esxB

EsxB

-3.48

SAUSA300_1754

splE

Serine protease SplE

-3.27

SAUSA300_1756

splC

Serine protease SplC

-2.89

SAUSA300_1768

lukD

Leukotoxin LukD

-2.77

SAUSA300_0949

sspC

Staphostatin B

-2.56

SAUSA300_1753

splF

Serine protease SplF

-2.55

SAUSA300_1919

scinA

Staph complement inhibitory protein A

-2.46

!
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SAUSA300_2164

eapH1

SAUSA300_2366
SAUSA300_1757

Function

Fold Change

MAP/EAP domain protein

-2.43

hlgC

Gamma-hemolysin component C

-2.29

splB

Serine protease SplB

-2.16

SAUSA300_0370

selX

Staphylococcal enterotoxin-like toxin X

-2.15

SAUSA300_1755

splD

Serine protease SplD

-2.04

!

!

!
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Aceytletransferases
SAUSA300_0643

GNAT Acetyltransferase

2.08

SAUSA300_1225

Aspartate kinase

3.28

Amino Acid Biosynthesis

SAUSA300_1046

sdhC

Succinate dehydrogenase, cytochrome b-558 subunit

2.88

SAUSA300_1686

murC

UDP-N-acetylmuramate-alanine ligase

2.56

SAUSA300_0184

argB

Acetylglutamate kinase

2.42

2-oxoglutarate dehydrogenase subunit E1, beta subunit

2.23

Ribose-phosphate pyrophosphokinase

2.09
2.01

SAUSA300_1465
SAUSA300_0478

prs

SAUSA300_0458

ldcC

Arginine/lysine/ornithine decarboxylases

SAUSA300_0648

vraG

Drug ABC transporter

5.29

SAUSA300_2128

sdrM

Multi-drug resistance transporter

2.26

Antibiotic Resistance

Cell Division
SAUSA300_1072

mraZ

Cell division protein

4.71

SAUSA300_1337

gpsB

Cell division protein

4.64

SAUSA300_1445

scpA

Segregation and condensation protein A

2.72

SAUSA300_1444

scpB

Chromosome segregation and condensation protein B

2.30

Cell Surface Associated
SAUSA300_1257

LytR-CpsA-Psr family protein

3.08

SAUSA300_2130

UTP-glucose-1-phosphate uridylyltransferase

2.97

SAUSA300_2586

asp2

Secondary Sec system accessory secretory protein

2.12

SAUSA300_2582

gtfB

GT1 glycosyltransferase - modifies SraP

2.02

Cell Wall Metabolism
SAUSA300_1076

mraY

Phospho-N-acetylmuramoyl-pentapeptide-transferase

2.06

DNA Replication, Recombination and Repair
SAUSA300_1251

parC

DNA topoisomerase IV, A subunit

2.94

SAUSA300_1346

dnaQ

DnaQ family exonuclease/DinG family helicase

2.87

SAUSA300_1522

dnaG

DNA primase

2.67

SAUSA300_1592

recJ

Single-stranded-DNA-specific exonuclease

2.63

SAUSA300_0367

ssb

single-strand binding protein

2.33

DNA polymerase IV

2.08

Exodeoxyribonuclease VII, large subunit

2.01

SAUSA300_1876
SAUSA300_1472

xseA

Membrane Protein

!

SAUSA300_2448

Putative membane protein

5.88

SAUSA300_1352

Putative membane protein

3.54

SAUSA300_2131

Putative membane protein

3.29

SAUSA300_2095

Membrane protein

3.23

SAUSA300_1241

Membrane protein

3.23

SAUSA300_0582

Hypothetical Membrane Protein

3.14

SAUSA300_1017

Membrane protein

2.82
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SAUSA300_0694

Hypothetical Membrane Protein

2.71

SAUSA300_0640

Membrane protein

2.61

SAUSA300_2046

Putative membane protein

2.52

SAUSA300_2297

Hypothetical Membrane Protein

2.52

SAUSA300_0678

Membrane protein

2.37

SAUSA300_1877

Membrane protein

2.33

SAUSA300_0603

Putative membane protein

2.21

SAUSA300_0729

Membrane protein

2.11

SAUSA300_1247

Putative thioesterase

5.03

SAUSA300_1456

Alpha-D-1,4-glucosidase

4.42

Metabolism

SAUSA300_2443

gntK

Gluconate kinase

3.02

SAUSA300_2064

atpB

ATP synthase F0 subunit A

2.79

L-threonine dehydrogenase

2.62

Phosphatidate cytidylyltransferase

2.61

Haloacid dehalogenase-like hydrolase

2.58

SAUSA300_0538
SAUSA300_1154

cdsA

SAUSA300_1069
SAUSA300_1550

Methyltransferase

2.39

SAUSA300_2529

phnB

Putative 3-demethylubiquinone-9 3-methyltransferase

2.35

SAUSA300_1124

fabG

3-oxoacyl-(acyl-carrier-protein) reductase

2.35

Phosphatidic acid phosphatase/phospholipid phosphatase

2.32

SAUSA300_1310
SAUSA300_0627

tagX

Glycosyltransferase

2.30

SAUSA300_1015

ctaA

Cytochrome oxidase assembly protein

2.23

SAUSA300_2057

atpC

ATP synthase F1 epsilon subunit

2.15

SAUSA300_1616

hemD

Uroporphyrinogen-III synthase

2.13

SAUSA300_0788

Nitroreductase

2.13

SAUSA300_2499

crtM

4,4′-diapophytoene synthase

2.10

SAUSA300_1123

fabD

Malonyl CoA-acyl carrier protein transacylase

2.08

Putative hydrolase

2.08

SAUSA300_0874
SAUSA300_1618

hemX

Cytochrome C assembly protein

2.05

Cofactor Biosynthesis
SAUSA300_0944

menA

1,4-dihydroxy-2-naphthoate octaprenyltransferase

2.93

SAUSA300_1872

cobQ

Cobyric acid synthase

2.44

SAUSA300_2073

tdk

SAUSA300_2303

tcaR

Nucleotide Biosynthesis

SAUSA300_0488

!

Thymidine kinase

3.39

TcaR

2.71

Hypoxanthine phosphoribosyltransferase

2.63

SAUSA300_0974

purN

Phosphoribosylglycinamide formyltransferase

2.49

SAUSA300_0973

purM

Phosphoribosylformylglycinamidine cyclo-ligase

2.42

SAUSA300_0968

purC

Phosphoribosylaminoimidazole-succinocarboxamide synthase

2.33

SAUSA300_1091

pyrR

Bifunctional pyrimidine regulatory protein PyrR/uracil phosphoribosyltransferase

2.23

SAUSA300_0386

xpt

Xanthine phosphoribosyltransferase

2.19
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SAUSA300_1358

ndk

SAUSA300_0975

purH

Function

Fold Change

Nucleoside diphosphate kinase

2.09

Bifunctional purine biosynthesis protein

2.01

Phage Proteins
SAUSA300_0814
SAUSA300_2506

isaA

Abortive infection bacteriophage resistance protein

3.87

Immunodominant staphylococcal antigen A

3.79

SAUSA300_1961

PhiPVL ORF41-like protein

2.72

SAUSA300_1432

PhiSLT ORF78-like protein

2.69

SAUSA300_1965

Hypothetical protein

2.69

SAUSA300_1437

PhiSLT ORF204-like protein

2.55

SAUSA300_1921

Truncated amidase

2.37

SAUSA300_2578

YhgE/Pip

2.11
Protein Biosynthesis

SAUSA300_0529

Ribosomal L7Ae superfamily

7.27

SAUSA300_0932

CAA-X Processing Protease

5.57

SAUSA300_1817

tRNA

5.06

SAUSA300_1776

tRNA

4.52

SAUSA300_0523

rplA

Ribosomal protein L1

3.75

SAUSA300_0524

rplJ

50S ribosomal protein L10

3.66

RNA ligase or phosphoesterase

3.62

30S ribosomal protein S12

3.44

SAUSA300_0366

Ribosomal protein S6

3.21

SAUSA300_1694

tRNA (guanine-N(7)-)-methyltransferase

3.04

SAUSA300_2603

Triacylglycerol lipase

3.02

Ribosome binding factor

2.93

SAUSA300_0926

tRNA

2.90

SAUSA300_1772

tRNA

2.82

SAUSA300_0916
SAUSA300_0530

SAUSA300_1163

rpsL

rbfA

SAUSA300_0532

fusA

Translation elongation factor G

2.71

SAUSA300_2190

rpsH

30S ribosomal protein S8

2.68

30S ribosomal protein S7

2.58

Trigger Factor

2.58

SAUSA300_1602

Putative ribosomal protein?

2.57

SAUSA300_1348

tRNA CCA-pyrophosphorylase

2.56

SAUSA300_1832

tRNA

2.56

SAUSA300_1161

Ribosomal L7Ae superfamily

2.53

50S ribosomal protein L23

2.51

SAUSA300_0181

Nonribosomal peptide synthetases

2.47

SAUSA300_2072

Peptide chain release factor 1

2.46

SAUSA300_2071

Protein-glutamine methyltransferase

2.36

Queuine tRNA-ribosyltransferase

2.32

tRNA

2.27

Ribosome-associated GTPase

2.22

SAUSA300_0531
SAUSA300_1622

SAUSA300_2202

SAUSA300_1595

tig

rplW

tgt

SAUSA300_1831
SAUSA300_1364
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Table 6. Continued
Annotation

Gene

SAUSA300_2185

rplO

50S ribosomal protein L15

2.21

SAUSA300_2192

rplE

50S ribosomal protein L5

2.19

tRNA

2.18
2.04

SAUSA300_1066

Function

SAUSA300_2172

rplM

50S ribosomal protein L13

SAUSA300_1443

rluB

Ribosomal large subunit pseudouridine synthase B

Fold Change

2.02

Regulators
SAUSA300_0928

comK

Regulator of competence

3.97

TetR transcriptional regulator

3.69

Regulator of biofilm

3.46

Xre regulator

3.29

SAUSA300_1809

Putative toxin regulator

3.20

SAUSA300_1888

TrpR homolog

3.17

SAUSA300_2322
SAUSA300_0653

rbf

SAUSA300_1797

xdrA

SAUSA300_2559

nsaR

NsaR response regulator

2.91

SAUSA300_1237

lexA

LexA repressor

2.63

Fructose operon repressor

2.55

spxA

Regulatory protein spx

2.30

SAUSA300_1995

scrR

Sucrose operon repressor

2.15

SAUSA300_1190

glpP

Glycerol uptake operon antiterminator regulatory protein

2.09

SAUSA300_0022

yycH

YycH protein

2.00

SAUSA300_0683
SAUSA300_0898

Stress Response
SAUSA300_2639

cspD

Cold shock protein D

15.28

SAUSA300_0777

cspC

Cold shock protein C

3.92

SAUSA300_2332

Heat shock protein

2.47

SAUSA300_1474

Asp23 superfamily; alkaline shock protein

2.38

Anti-sigma factor

2.27

SAUSA300_2024

rsbV

Transcription
SAUSA300_2037

srmB

SAUSA300_1160
SAUSA300_1722

sigS

Superfamily II DNA and RNA helicases

5.41

Transcription terminator

4.32

ECF family sigma factor

2.08
Transport

SAUSA300_1374

Hypothetical riboflavin transporter

10.38

SAUSA300_2324

PTS system, sucrose-specific IIBC component

8.23

SAUSA300_0448

treP

PTS system, trehalose-specific IIBC component

5.18

SAUSA300_1245

opuD

Glycine betaine transporter

4.35

MFS transporter

3.76

mnhF

Monovalent cation/H+ antiporter subunit F

3.40

SAUSA300_0625

tagG

Teichoic acids export protein permease protein

3.40

SAUSA300_0849

mnhG

Monovalent cation/H+ antiporter subunit G

3.16

SAUSA300_0977

ABC-type cobalt transport system, permease component

3.10

SAUSA300_0649

PhoU transporter

2.71

Xanthine/uracil/vitamin C permease family protein

2.69

SAUSA300_2449
SAUSA300_0850

SAUSA300_2207
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Table 6. Continued
Annotation

Gene

Function

Fold Change

SAUSA300_0978

ABC-type cobalt transport system, ATP-binding component

2.68

SAUSA300_0633

Iron compound ABC transporter, ATP-binding protein

2.44

SAUSA300_1285

ABC transporter

2.32

SAUSA300_2323

Magnesium transporter

2.28

mnhC

Monovalent cation/H+ antiporter subunit C

2.22

SAUSA300_0670

cydD

ABC-type transport system, cytochrome bd, cystine, glutathione

2.18

SAUSA300_1913

pmtA

PSM essential transporter

2.09

SAUSA300_0650

Inorganic phosphate transporter

2.08

SAUSA300_1252

Na+/alanine symporter

2.02

SAUSA300_2212

Unknown

5.79

SAUSA300_0781

Unknown

4.07

SAUSA300_1739

Unknown

3.96

SAUSA300_0957

Unknown

3.49

SAUSA300_0642

Unknown

2.97

SAUSA300_0639

Unknown

2.88

SAUSA300_1904

Unknown

2.86

SAUSA300_0826

Unknown

2.83

SAUSA300_1353

Unknown

2.80

SAUSA300_1789

Unknown

2.41

SAUSA300_2620

Unknown

2.35

SAUSA300_1577

Unknown

2.29

SAUSA300_1372

Unknown

2.22

SAUSA300_1011

Unknown

2.15

SAUSA300_1010

Unknown

2.01

SAUSA300_0853

Unknown Function

Virulence Associated
SAUSA300_1989

agrB

Accessory gene regulator protein B

2.98

SAUSA300_1992

agrA

Accessory gene regulator protein A

2.44

Fibronectin-binding protein

2.43

SAUSA300_1101

!

SAUSA300_1052

ehb

Ehb complement inhibitory protein

2.30

SAUSA300_1990

agrD

Accessory gene regulator protein D

2.24

SAUSA300_2565

clfB

Clumping factor B

2.14

SAUSA300_0801

seq

Enterotoxin Q

2.05
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every ecological niche of the human body.

With such a complex lifestyle it would be

unsurprising if the genome of S. aureus encoded a multitude of ECF sigma factors in order to
facilitate infection. However, to date only one (σS) has been described (Shaw et al., 2008).
It is a hallmark of ECF sigma factors to be transcriptionally linked to a gene encoding a
transmembrane anti-sigma factor that prevents the sigma factor from associating with coreRNAP (Helmann, 1999), (Hughes & Mathee, 1998). We demonstrate herein that the sigS locus
is tightly conserved amongst the staphylococci, and consists only of σS, and three other genes.
When looking at the down stream gene, ecfX, it does appear to be transcriptionally linked to sigS
but does not contain any transmembrane domains. With that said, cytoplasmic anti-sigma factors
have been described, such as RsrA, which regulates the ECF sigma factor σR of S. coelicolor
(Kang et al., 1999). When we evaluated the effect of a mutation in ecfX, we unexpectedly
observed a significant decrease in sigS expression, rather than the typical increase demonstrated
by anti-sigma factor inactivation in other organisms (Helmann, 1999), (Hughes & Mathee,
1998), (Schurr, Yu, Martinez-Salazar, Boucher, & Deretic, 1996). Curiously, we observed that in
an archaic staphylococcal strain, S. carnosus, the sigS and ecfX genes are annotated as a single
open reading frame that encodes one protein. Therefore, we hypothesize that the sigS and ecfX
genes may have arisen as a single unit that has since diverged into two separate genes/proteins,
but that may still function together. In order to confirm this, we performed protein pull down
assays with purified σS and EcfX and found that these two proteins do in fact interact with each
other. Thus, these results would suggest that σS and EcfX may function together in order to bring
about changes in gene expression in response to stress. This is supported, at least in part, by the
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observation that EcfX possesses a ComK domain, which has been shown to bind DNA and
regulate gene expression in a number of other organisms.
Downstream of ecfX in the conserved sigS cluster is ecfY, which specifies a protein predicted to
have 2 transmembrane domains: thus making it a more likely candidate to serve as an anti-sigma
factor. Interestingly, RNAseq analysis revealed that the majority of transcription in the sigS locus
actually arises from an extended ecfY 3’ UTR that continues to run through ecfX and sigS. In
order to determine if this is the reason for the low levels of sigS and ecfX expression we have
previously observed (Miller et al., 2012), (Shaw et al., 2008), we performed qPCR analysis on a
strain lacking the ecfY transcript, and found a significant increase in both sigS and ecfX
expression. Classically, ECF sigma factors are regulated by an anti-sigma factor through proteinprotein interaction (Helmann, 1999). However, our work suggests that sigS is being regulated by
ecfY through RNA-RNA interaction of the extended 3’ end of the ecfY transcript. To validate
this hypothesis, we constructed two ecfY complement strains that contain either the coding region
of ecfY alone (ecfY-S), or the coding region and the extended 3’ UTR (ecfY-L). Importantly, we
found that only the ecfY-L complement was able to suppress sigS and ecfX transcription,
indicating that it is the ecfY extended 3’ UTR, rather than the EcfY protein that is responsible for
the low level of expression of these two genes.
We have previously shown that sigS mutants of S. aureus have impaired survival upon challenge
with H2O2, ethidium bromide, and MMS (Miller et al., 2012). Given that the ecfY disrupted strain
displays enhanced sigS expression we hypothesized that this mutant may display increased
survival in response to these situations compared not only to a sigS mutant, but the parental
strain as well. Upon analysis we did indeed observe these effects, with the ecfY knock-down

!

78!

strain proving better able to survive oxidative and DNA damage stress compared to the wildtype. We again used our complementation constructs to explore these findings further,
hypothesizing that if EcfY was regulating σS via protein-protein interaction, we would be able to
complement our phenotypes with both complement strains. Conversely, if the regulation was
occurring through RNA-RNA interaction, then we would only be able to complement our
experiments with the ecfY coding region and extended 3’ UTR.

We determined that

complementation of these phenotypes was only possible for the construct containing ecfY and the
extended 3’ UTR, which again indicates that ecfY is regulating sigS through RNA-RNA
interaction.
The opposing phenotypes described herein are not uncommon when the negative regulator of an
ECF sigma factor is disrupted. Indeed, when MucA, the anti-sigma factor of AlgU, is mutated in
the opportunistic pathogen, P. aeruginosa, this leads to an increase in this organisms ability to
survive phagocytosis by human leukocytes (Schurr et al., 1996), (Schwarzmann & Boring,
1971). Additionally, CarQ is an ECF sigma factor in the Gram-negative organism Myxococcus
xanthus that controls carotenoid biosynthesis. This leads to protection against reactive oxygen
species (ROS) produced in response to light (Galbis-Martinez et al., 2008). Inactivation of the
cognate anti-sigma factor, CarR, results in increased resistance to photolysis in Myxococcus
xanthus strains (Burchard & Dworkin, 1966), (McGowan, Gorham, & Hodgson, 1993),. A
consideration with these examples is that they each are the result of ECF-sigma factor repression
at the protein level, however we show herein that regulation of σS expression/activity is
seemingly occurring via RNA-RNA interaction, which has not been described in ECF sigma
factors biology to date. Such approaches have been demonstrated for the stationary phase sigma
factor σS in E. coli (despite sharing the same name, these two proteins are not functional
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homologs) (Hammerle, Vecerek, Resch, & Blasi, 2013), (Soper & Woodson, 2008). Specifically,
the σS encoding transcript (rpoS) forms a stem-loop secondary structure that sequesters its own
ribosomal binding site, and thereby inhibits translation (Soper & Woodson, 2008). At low
temperatures, the small regulatory RNAs DsrA and RprA interact with rpoS to open this
inhibitory stem-loop structure and facilitate translation (Brown & Elliott, 1997), (Majdalani,
Chen, Murrow, St John, & Gottesman, 2001; Majdalani, Cunning, Sledjeski, Elliott, &
Gottesman, 1998). As such, there is precedence for RNA-based regulation of sigma factor
activity in the literature, although as yet, not for those from the ECF family.
Any attempts to explore the σS regulon have thus far been confounded by a lack of sigS
expression under standard conditions, and an inability to generate a sigS overexpressing strain
(likely due to inhibition by the ecfY transcript’s 3’ UTR). Given that we demonstrate sigS
overexpression in the ecfY null strain, we consequently used it in RNAseq analysis so as to
identify σS controlled genes. In so doing, we identified a decrease in the expression of cymR and
lacR, which we have previously demonstrated to negatively regulate sigS expression (Burda et
al., 2014). CymR encodes the master regulator of cysteine biosynthesis in S. aureus (Soutourina
et al., 2010; Soutourina et al., 2009), and has been previously implicated in the response to
oxidative damage in S. aureus (Soutourina et al., 2010; Soutourina et al., 2009). Importantly,
there was also a decrease in expression for several genes in the ecfY knock-downs strain that
have previously been shown to be directly regulated by CymR, such as the trx, cysK, cysM,
ahpC, sodM and sodA. We have previously shown that sigS expression is induced during
oxidative stress, and sigS mutants are more sensitive to ROS, whereas our sigS over-expressing
strrain (the ecfY null strain) is more resistant to this type of damage (Burda et al., 2014). As such,
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these results indicate a reciprocal relationship of regulation likely exists between CymR and σS
that strongly influences with response of S. aureus to ROS mediated stress.
We also identified alterations in expression of ahpC, which encodes an alkyl hydroperoxide
reductase. The AhpC enzyme is responsible for scavenging H2O2 in S. aureus, and mutants that
lack the ahpC gene have been shown to be more resistant when exposed to this agent (Cosgrove
et al., 2007). Accordingly, the decrease in expression of this gene goes some way towards
explaining the increase in resistance of the ecfY null strain to H2O2, likely via sigS
overexpression.
We also observed major changes in expression of genes involved in the de novo assembly of
nucleotides:

purC

(phosphoribosylaminoimidazol-succinocarboxamide

synthase),

purH

(bifunctional purine biosynthesis gene), purM (phosphoribosylformylglycinamidine clycloligase), purN (phosphoriobylglycinamide formyltransferase), pyrH (bifunctional pyrimidine
regulatory protein/uracil phosphoribosyltransferase) and tdk (thymidine kinase), which were all
strongly upregulated in the ecfY knock-down strain. Interestingly, we have previously identified
the expression and activity of genes that are involved in purine biosynthesis as being positively
influence by σS in strain RN4220 Miller and Shaw, unpublished observation. We suggest that
these findings may, at least in part, explain the sensitivity of sigS mutants (and resistance of ecfY
mutants) to DNA damage, as previous studies have shown the vital importance of de novo
nucleotide synthesis for surviving this type of stress (Valentino et al., 2014). Furthermore, recent
studies have demonstrated that the de novo assembly of purines is vital to pathogenesis in S.
aureus, E. coli, S. enterica, and B. anthracis (McFarland & Stocker, 1987), (Mei, Nourbakhsh,
Ford, & Holden, 1997), (Samant et al., 2008), (Valentino et al., 2014). Therefore, it is plausible
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that the attenuation of virulence observed for the sigS mutant strains may be due to depleted
purine pools in vivo (Shaw et al., 2008).
We also identified increased expression of other genes in the ecfY transposon mutant that are
involved in DNA replication, recombination and repair. Specifically we noted an increase in
expression of recJ, which encodes a single-stranded DNA-specific exonuclease. In E. coli, it has
been shown that recJ is responsible for degrading single stranded DNA as part of the
recombination repair pathway in response to damage such as that caused by UV irradiation
(Lovett & Kolodner, 1989). In addition, we also observed an increase in the ecfY null strain in
the expression of xseA, which encodes exodeoxyribonuclease VII.

In E. coli is has been

demonstrated that xseA is a part of the recombination repair pathway and is involved in
degrading DNA when exposed to UV irradiation (Repar, Briski, Buljubasic, Zahradka, &
Zahradka, 2013). As such, the resistance to UV irradiation demonstrated by the ecfY null strain,
and sensitivity of sigS mutants to this same stress, may be explained by σS mediated control of
the recombination repair pathway.
Previously our group has shown that sigS expression is upregulated by growth in amino acid
limiting media, and by the disruption of genes involved in the biosynthesis of amino acids
(Burda et al., 2014), (Miller et al., 2012). In connection with this, we observed increased
expression of genes that are involved amino acid biosynthesis in the ecfY transposon mutant.
This included argB (acetylglutamate kinase), which catalyzes the conversion of N-acetyl-Lglutamate to N-acetyl-L-glutamate phosphate in the second step of arginine biosynthesis, which
can be used to synthesize other amino acids, including proline (Cunin, Glansdorff, Pierard, &
Stalon, 1986), (Townsend, Kaenjak, Jayaswal, & Wilkinson, 1996). It also included prs (ribose-
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phosphate pyrophosphokinase), which is responsible for catalyzing the addition of a
pyrophosphoryl group to ribose-5-phosphate, generating phosphoribosyl diphosphate (PRPP), a
key intermediate in the biosynthesis of amino acids, purines and pyrimidines (Hove-Jensen,
1985). In B. subtilis, upregulation of prs leads to an increase in PRPP pools inside the cell,
which in turn leads to an increase in free amino acids, and more importantly, nucleotides (Zhu,
Yang, Yuan, & Ban, 2015). Our observation that prs is increased in an ecfY null strain may lead
to such increase in PRPP, and explain why this strain is more resistant to DNA damaging, while
a sigS mutant is more sensitive. As such, this would appear to connect the upregulation of sigS in
response to amino acids starvation, and the role of σS in de novo nucleotide biosynthesis.
Our previous works have also demonstrated that expression of sigS is induced upon exposure to
cell wall targeting antibiotics, and that a sigS mutant is more sensitive when exposed such
agents. RNAseq analysis reveals that in the ecfY null strain there is an increase in expression of
mraY, which encodes a phospho-N-acetylmuramoyl-pentapeptie-transferase that catalyzes the
initial step of peptidoglycan biosynthesis. In B. subtilis, overexpression of mraY leads to an
increase in MIC for a number of cell wall targeting antibiotics (Ishizaki et al., 2013). Thus it
follows that mraY levels in a sigS mutant would be decreased, resulting in the observed
sensitivity to cell-wall targeting antibiotics. Conversely, we identified a decrease in expression
for atl: the major autolysin of S. aureus, in the ecfY transposon mutant (Foster, 1995). This
autolysin is involved in cell wall turn over, contributing to the separation of daughter cells
following cell division, and to antibiotic induced lysis (Biswas et al., 2006), (Foster, 1995),
(Sugai et al., 1997). We have previously demonstrated that sigS expression in induced following
exposure to sodium dodecyl sulfate (SDS) and that sigS mutants are more susceptible to lysis by
Triton X-100 (Miller et al., 2012). These results suggest that σS may be responsible for the
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transcription of genes that are involved in cell wall biosynthesis in response to stress, while
indirectly repressing the transcription of genes that are involved in the degradation of the cell
wall.
Finally, reports by our group have demonstrated that sigS expression is important in the
virulence of S. aureus using both ex vivo and in vivo models of infection (Miller et al., 2012),
(Shaw et al., 2008). We describe here that an ecfY null strain is more resistant to phagocyte
mediated killing when compared to the sigS mutant and wild-type strain, suggesting that σS
influences the expression of genes central to the virulence process. Importantly, in this study we
observed an increase in expression in the ecfY knock-down strain of the accessory gene regulator
locus, agr, which encodes a two-component quorum sensing system that is vital to virulence in S.
aureus (Morfeldt, Janzou, Arvidson, & L fdahl, 1988), (Peng, Novick, Kreiswirth, Kornblum,
& Schlievert, 1988). Given that sigS is strongly over-expressed upon loss of the ecfY transcript, it
follows that σS may have some regulatory influence on the expression of agr, explaining the
virulence attenuation of sigS mutants. Additionally, RNAseq analysis also revealed an increase
in expression of a putative fibronectin binding protein (SAUSA300_1101), which has been
shown to be important in virulence. Additionally, we observed increase in expression of a
fibrinogen binding protein, clumping factor B. Previous studies have indicated that fibrinogen
mediated adherences is crucial in virulence using a rabbit model of endocarditis (Moreillon et al.,
1995).

Because of the importance to fibronectin binding during infection, the increase in

expression of these two genes indicates σS contributes to the ability S. aureus to establish an
infection, as we have already demonstrate its importance in the virulence of this pathogen. Our
observation that in the absence of ecfY leads to an increase in sigS expression and in resistances
to components of the innate immune response, coupled with what appears to be σS- mediated
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control of virulence associated gene indicates that sigS is important in both the establishment and
continuation of infection.
Herein, we present evidence of a unique occurrence whereby and ECF-sigma factor (σS) and a
putative DNA binding protein (EcfX) seemingly arose as a single transcriptional unit, and thus
protein, but have since diverged evolutionarily; yet still interact and seemingly function together
to bring about changes in gene expression.

Further to this, we identified an additional,

downstream gene (ecfY) that serves as a negative regulator of sigS expression by a novel
mechanism of RNA-RNA mediated interaction. In the absence of ecfY, S. aureus displays an
increased resistance DNA damaging agents and components of the innate immune response,
contrary to that which we have previously demonstrated for sigS mutants. RNAseq analysis was
performed on the ecfY null strain, as it is a sigS overexpression strain, in order to identify the σS
regulon. This analysis correlated tightly with previous work performed by our group on σS,
demonstrating a role for it in the DNA-damage response, virulence, amino acid starvation and
nucleotide biosynthesis (Burda et al., 2014), (Miller et al., 2012), (Shaw et al., 2008).
Collectively, we demonstrate that the ECF-sigma factor in S. aureus, σS, is regulated via unique
methods: positively thought the apparent need for an activator protein, and negatively via RNARNA interaction. We contend that this adds unique knowledge, not only to our understanding of
S. aureus regulatory circuits, but also to alternative sigma factor biology in general.
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CHAPTER FOUR:
ANTIBACTERIAL ACTIVITY OF A SERIES OF N2,N4-DISUBSTITUTED
QUINAZOLINE-2,4-DIAMINES
Note To Reader.

These results have been previously published (Burda et. al., 2014) with the

permission of the publisher and the published manuscript can be found in Appendix 2.
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CHAPTER FIVE:
FINAL DISCUSSION
Discussion. ECF sigma factors are the largest and most diverse subfamily of σ70 enzymes, and
typically respond to environmental stimuli (Helmann, 2002), (Llamas, Imperi, Visca, & Lamont,
2014). Indeed, many studies have demonstrated the importance of ECF sigma factors in the
virulence of pathogens, such as P. aeruginosa, M. tuberculosis, and H. influenzae (Agarwal et
al., 2007), (Bashyam & Hasnain, 2004), (Craig et al., 2002), (Llamas et al., 2014). Our group
has previously demonstrated the importance of the ECF sigma factor, σS, in the virulence of S.
aureus using a murine model of septic arthritis (Shaw et al., 2008). Curiously, we have also
observed that sigS is differentially expressed among a variety of S. aureus lineages, which we
hypothesized suggested a tight level of regulation.
It is a hallmark of ECF sigma factors to be transcriptionally linked to a gene encoding a
transmembrane anti-sigma factor that prevents the sigma factor from associating with coreRNAP (Helmann, 1999), (Hughes & Mathee, 1998). We demonstrate herein that the sigS locus
is tightly conserved amongst the staphylococci, and consists only of σS, and three other genes.
When looking at the down stream gene, ecfX, it does appear to be transcriptionally linked to sigS
but does not contain any transmembrane domains. With that said, cytoplasmic anti-sigma factors
have been described, such as RsrA, which regulates the ECF sigma factor σR of S. coelicolor
(Kang et al., 1999). When we evaluated the effect of a mutation in ecfX, we unexpectedly
observed a significant decrease in sigS expression, rather than the typical increase demonstrated
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by anti-sigma factor inactivation in other organisms (Helmann, 1999), (Schurr et al., 1996).
Curiously, we had previously noted that in an ancient staphylococcal species, S. carnosus, sigS
and ecfX genes are annotated as a single open reading frame that encodes one protein. Thus, we
hypothesized that the sigS and ecfX genes arose as a single unit that has since diverged into two
separate genes/proteins, but that may still function together.

In order to confirm this, we

performed protein pull down assays with purified σS and EcfX and observed that these two
proteins do in fact interact with each other. These results suggest that σS and EcfX work together
to bring about changes in gene expression in response to stress. This is supported by the
presence of a ComK domain in EcfX, which has been shown to bind to DNA and regulate gene
expression.
Downstream of ecfX in the conserved sigS locus is ecfY, which encodes a protein predicted to
have 2 transmembrane domains; thus making it a more likely candidate to serve as an anti-sigma
factor. Interestingly, RNAseq analysis revealed that the majority of transcription in the sigS
locus actually arises from an extended ecfY 3’ UTR that continues to run through ecfX and sigS.
In order to determine if this is the reason for the low levels of sigS and ecfX expression we have
previously observed (Miller et al., 2012), (Shaw et al., 2008), we performed northern blot
analysis and confirmed our RNAseq results. Therefore, we hypothesize that ecfY might regulate
sigS and ecfX through this extended 3’ UTR, which is supported by qPCR analysis
demonstrating an ecfY knock down strain has significantly increased sigS and ecfX expression.
Classically, ECF sigma factors are regulated by a cognate anti-sigma factor through proteinprotein interaction; however, our findings suggest that ecfY is regulating sigS through RNA-RNA
interaction via its extended 3’UTR. In order to test our hypothesis, we constructed two ecfY
complements strains that contain either the coding region of ecfY alone (ecfY-S), or the coding
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region and the extended 3’ UTR (ecfY-L). We observed that only when we complemented with
the ecfY-L complement were we able to restore transcription of sigS to wild-type levels,
indicating that it is the extended 3’UTR of ecfY, and not the EcfY protein that is responsible for
the low level of expression of these two genes.
When assessing the effect an ecfY mutation had on previously described sigS phenotypes, we
found that they were opposing in nature. Specifically, an ecfY null strain was more resistant to
H2O2, MMS, ethidium bromide and UV irradiation when compared to both the wild-type and
sigS mutant.

We attributed the increase in resistance to these DNA damaging agents to

overexpression of sigS.

Again, we used our complementation constructs to explore these

findings further, hypothesizing that if EcfY was regulating σS via protein-protein interaction, we
would be able to complement our phenotypes with both complement constructs. Conversely, if
the regulation was occurring through RNA-RNA interaction, then we would only be able to
complement our experiments with the ecfY coding region and extended 3’ UTR. We determined
that complementation of these phenotypes was only possible for the construct containing ecfY
and the extended 3’ UTR, which again indicates that ecfY is regulating sigS through RNA-RNA
interaction.
Herein, we describe that ecfY is regulating sigS via RNA-RNA interaction, a phenomenon that
has not been documented for ECF sigma factors, to date. RNA-RNA mediated regulation has
been described for the stationary phase sigma factor σS in E. coli (Hammerle et al., 2013), (Soper
& Woodson, 2008). The rpoS transcript, which encodes σS, forms a stem-loop secondary
structure that sequesters the ribosomal binding sight and thereby inhibiting translation (Soper &
Woodson, 2008). At low temperatures, the small regulatory RNAs DsrA and RprA interact with
the rpoS transcript to open this inhibitory stem-loop structure and facilitate translation (Brown &
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Elliott, 1997), (Majdalani et al., 2001; Majdalani et al., 1998). Conversely to that described for
rpoS, in this present study we describe a situation where an extended 3’UTR is interacting with
the transcript of sigS and ecfX to inhibit translation of these genes.
In order to further explore the regulatory network modulating sigS expression, we also used a
variety of approaches that include a biotin pull down assay, a forward and reverse transposon
screen, and an NTG screen. The results of these experiments support our previous studies of σS
playing a role in amino acid, cell wall and nucleotide biosynthesis, and in the virulence of S.
aureus (Miller et al., 2012), (Shaw et al., 2008).

In addition, our findings are further

corroborated by RNAseq analysis performed on our ecfY null strain, which is essentially a sigS
overexpressing strain.
Our biotin pull down assay identified one transcriptional regulator, CymR that interacts with the
promoter region of sigS.

Using qPCR, we demonstrated that there is an increase in sigS

expression in the absence of cymR, indicating that it is a negative regulator of sigS. In order to
validate the results of our biotin pull down assay, we performed electrophoretic mobility shift
assays using purified CymR and observed that this protein does indeed bind to the promoter
region of sigS. In S. aureus, CymR is the master regulator of cysteine biosynthesis and represses
the transcription of 18 genes that are organized into 8 transcriptional units (Soutourina et al.,
2010; Soutourina et al., 2009). Soutourina et. al. has demonstrated that a cymR mutant is more
sensitive when exposed to hydrogen peroxide, which is a phenotype that we have also described
for sigS (Miller et al., 2012), (Soutourina et al., 2010; Soutourina et al., 2009). Interestingly, our
RNAseq analysis of the ecfY null strain revealed a decrease in the expression of cymR, which
might indicate a negative feed back loop, whereby σS may be involved in the transcription of a
negative regulator of cymR in order to promote its own expression under stressful conditions. In
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addition, there is also a down regulation of several genes in the ecfY knock-down strain that have
previously been shown to be directly regulated by CymR, such as the trx, cysK, cysM, ahpC,
sodM and sodA. We have previously shown that sigS expression is induced during oxidative
stress, and sigS mutants are more sensitive to ROS, whereas our ecfY null strain is more resistant
to this type of damage. As such, these results indicate a reciprocal relationship of regulation
likely exists between CymR and σS that strongly influences the response of S. aureus to ROS
mediated stress.
In connection with these findings, we identified alterations in expression of ahpC, which encodes
an alkyl hydroperoxide reductase. The AhpC enzyme is responsible for scavenging H2O2 in S.
aureus and mutants that lack the ahpC gene have been shown to be more resistant when exposed
to this agent (Cosgrove et al., 2007). We observed a decrease in expression of this gene in the
ecfY null strain, which would explain the increase in resistance an ecfY null strain when exposed
to H2O2. In addition, we observed increased expression of a putative cysteine and glutathione
transporter, cydD, suggesting that σS may regulate genes that are involved in transporting these
components from the environment. Notably, glutathione and thioredoxin are cysteine-containing
molecules that are important in the protection against oxidative stress (Carmel-Harel & Storz,
2000), (Dickinson & Forman, 2002), (Gleason & Holmgren, 1988), (Masip, Veeravalli, &
Georgiou, 2006), (Penninckx & Elskens, 1993), (Zeller & Klug, 2006). In addition, there have
been several studies that have demonstrated cysteine itself has a role in the ability of bacteria to
sense oxidative stress (Lithgow, Hayhurst, Cohen, Aharonowitz, & Foster, 2004), (S. Park &
Imlay, 2003). Indeed, in the Gram-positive organism Lactobacillus reuteri, cysteine has been
shown to protect the cell from H2O2 stress (Lo et al., 2009). This suggests that σS mediated
repression of cymR would lead to an increase in cysteine biosynthesis, which could be used to
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sense oxidative stress, as well as being incorporated into enzymes that are involved in
detoxification following ROS challenge.
Our transposon assay to identify negative regulators, as well as our NTG screen, both revealed a
mutation in lacR as having a strong influence on sigS expression. In S. aureus, the lacR gene
encodes the lactose operon repressor, which is responsible for negatively regulating the
expression of genes involved in the transport and utilization of lactose (Oskouian & Stewart,
1990). Using qPCR analysis we confirmed that in absence of lacR there is an increase in the
expression of sigS; however, EMSA analysis revealed that LacR is not a direct regulator. In
addition, our RNAseq analysis reveals a significant decrease in expression of lacR in the ecfY
knock down strain. These results would suggest that perhaps there is a negative feedback loop in
which σS may be involved in the transcription of a negative regulator of lacR in order to promote
its own expression under stressful conditions. Further to this, previous exploration of the sigS
regulon by our group suggests that this sigma factor is involved in regulating expression of lacA,
lacB and lacD, as we demonstrate a decrease in expression of these genes in a sigS mutant
(Miller, 2012). These results would suggest that sigS plays a role in the ability of S. aureus to
utilize secondary carbon sources, such as lactose, and may also explain why our sigS mutant is
unable to compete with the parent strain during starvation, as demonstrated by coculture analysis
(Shaw et al., 2008). Therefore, it is plausible that sigS plays a role overcoming starvation in S.
aureus and that LacR indirectly represses expression of this sigma factor when it is grown under
nutrient rich conditions.
Preliminary work by our group suggests that σS plays a role in regulating genes that are involved
in the de novo assembly of nucleotides (Miller, 2012). The results of our transposon screen
corroborate these findings as we identified that inactivation of the gene encoding the nucleoside
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permease, nupC led to an increase in sigS expression. NupC is hypothesized to be the primary
pyrimidine transporter in S. aureus because of the high sequence similarity to NupC in B. subtilis
(Kriegeskorte et al., 2014), (Saxild, Andersen, & Hammer, 1996). In addition, Kriegeskorte et.
al. demonstrated that a nupC mutant was unable to import extracellular thymidine into S. aureus
(Kriegeskorte et al., 2014). It would thus stand to reason that if cells were unable to import
pyrimidines then they would have to synthesize them, and we have previously observed that sigS
is involved in regulating genes that are involved in de novo nucleotide biosynthesis (Miller,
2012). Further to this, our RNAseq results reveal there to be an increase in the expression of
genes

involved

in

the

de

novo

assembly

(phosphoribosylaminoimidazol-succinocarboxamide
biosynthesis

gene),

purM

of

nucleotides,

synthase),

purH

(phosphoribosylformylglycinamidine

such

as

purC

(bifunctional

purine

clyclo-ligase),

purN

(phosphoriobylglycinamide formyltransferase), pyrH (bifunctional pyrimidine regulatory
protein/uracil phosphoribosyltransferase) and tdk (thymidine kinase) in the ecfY knock-down
strain. We suggest that these findings may, at least in part, explain the sensitivity of sigS mutants
(and resistance of ecfY mutants) to DNA damage, as previous studies have shown the vital
importance of de novo nucleotide synthesis for surviving this type of stress (Valentino et al.,
2014), (Mei et al., 1997). Furthermore, recent studies have demonstrated that the de novo
assembly of purines is vital to pathogenesis in S. aureus, E. coli, S. enterica, and B. anthracis
(McFarland & Stocker, 1987), (Mei et al., 1997), (Samant et al., 2008), (Valentino et al., 2014).
Therefore, it is plausible that the attenuation of virulence observed for sigS mutant strains may be
due to depleted purine pools in vivo (Shaw et al., 2008).
Our group has previously demonstrated a role for sigS in amino acid starvation, in that its
expression is up regulated in amino acid limiting media (Miller et al., 2012). Therefore, it is
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unsurprising that we also identified insertions in a number of genes that are involved in amino
acid biosynthesis. The transposon screen used to identify negative regulators revealed that
insertions in sucB, sucA, and ald led to an increase in sigS expression. The genes sucA and sucB
encode the 2-oxoglutarate system, while ald encodes alanine dehydrogenase. The products of
these three genes are responsible for converting amino acids into important intermediates in the
tricarboxylic acid cycle (TCA), which in turn are used to create other amino acids and
nucleotides. Moreover, our transposon screen in which we induced expression of sigS using the
DNA damaging agent MMS, also revealed a number of insertions in genes that are involved in
amino acid biosynthesis. These include the amino acid permease, potE, the large subunite of
acetolactate

synthase,

ilvB,

a

branch

chain

amino

acid

transporter,

brnQ3,

and

phosphoribosylanthranilate isomerase, trpF all of which lead to a decrease in the expression of
sigS. These results suggest that if cells are unable to synthesize and/or import amino acids, then
S. aureus cannot upregulate sigS in order to over come amino acid starvation. In connection with
these findings, RNAseq analysis of the ecfY null strain revealed increased expression of genes
that are involved amino acid biosynthesis such as argB (acetylglutamate kinase) and prs (ribosephosphate pyrophosphokinase). Acetylglutamate kinase catalyzes the conversion of N-acetyl-Lglutamate to N-acetyl-L-glutamate phosphate in the second step of arginine biosynthesis, which
is then used to synthesize other amino acids, such as proline (Cunin et al., 1986), (Townsend et
al., 1996). Ribose-phosphate pyrophosphokinase is responsible for catalyzing the addition of a
pyrophosphoryl group to ribose-5-phosphate. The product of this reaction is phosphoribosyl
diphosphate (PRPP), which is a key intermediate in the biosynthesis of amino acids, purines and
pyrimidines (Hove-Jensen, 1985). In B. subtilis, upregulation of prs leads to an increase in
PRPP pools inside the cell, which in turn leads to an increase in free amino acids, and more

!

94!

importantly, nucleotides (Zhu et al., 2015). Our observation that prs is increased in an ecfY null
strain may lead to such increase in PRPP, and explain why this strain is more resistant to DNA
damage, while a sigS mutant is more sensitive. As such, this would appear to connect the
upregulation of sigS in response to amino acids starvation, and the role of σS in de novo
nucleotide biosynthesis.
Our transposon screen also identified a mutation in the response regulator, arlR, which is
involved in adhesion, autolysis and virulence, as producing an increase in sigS expression
(Fournier & Hooper, 2000). Fournier et. al. previously demonstrated that when exposed to the
detergent Triton X-100 an arlR mutant was more sensitive to killing, a phenotype that we have
previously described for sigS mutants (Fournier & Hooper, 2000), (Shaw et al., 2008). Liang et.
al performed microarrary analysis and demonstrated that arlRS negatively regulates expression
of the lacABCDEFG operon, which is negatively regulated by LacR, thus suggesting a
connection between the influence of ArlR and LacR on sigS expression (Liang et al., 2005).
Further to this, it is plausible that the increase in expression of the lacABCDEFG operon in the
absence of arlR is due to an increase in expression of sigS and thus σS mediated transcription of
genes involved in the utilization of secondary carbon sources. Liang et. al. also demonstrated
that arlR negatively regulates ebh, another gene that was identified in our transposon screen as
negatively influencing sigS expression (Liang et al., 2005). The ebh gene encodes a large
surface protein that is involved in adhesion and virulence. Further to this, several studies have
demonstrated that a lack of ebh leads to instability of the S. aureus cell wall (Cheng, Missiakas,
& Schneewind, 2013), (Kuroda et al., 2001). In addition, Cheng et. al. demonstrated that an ebh
mutant is also more sensitive to killing by Triton-X100 and osmotic stress (Cheng et al., 2013).
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Thus, these results could suggest that in the absence of alrR and ebh, sigS is upregulated in order
to combat cell wall instability
In our NTG screen we identified a mutation in the membrane sensor histidine kinase, kdpD that
negatively influences sigS expression. Interestingly, Liang et. al. also demonstrated that arlR
negatively regulates expression of the two-component system, kdpDE (Liang et al., 2005). The
KdpDE system has been shown to be responsible for sensing and responding to potassium levels
inside the cell and oxidative stress, as well as influencing virulence and intracellular survival
(Chitnis, Freeman, Dorus, & Waterfield, 2013), (Xue et al., 2011).

KdpDE’s role in the

intracellular survival has been linked to the regulation of genes involved in responding to
oxidative stress, which we have previously demonstrated sigS to be involved in (Miller et al.,
2012). Thus these results may indicate that during intracellular survival there is derepression of
sigS by KdpE in order to combat oxidative damage caused by phagocytes. In addition, this
derepression is independent of arlR because this response regulator negatively regulates both
sigS and kdpDE expression.
We also identified mutations in two cell envelope associated genes in our transposon screen as
having an increase in sigS expression, ebh, which we described above, and femB. The femB gene
forms an operon with femA and has been shown to be involved in peptidoglycan biosynthesis by
the catalyzing the formation of the pentaglycine peptide bridge (Kopp, Roos, Wecke, &
Labischinski, 1996). This inability of femB mutants to properly assemble the cell wall leads to
an increase in sensitivity to β-lactam antibiotics as demonstrated by Kopp et. al. (Kopp et al.,
1996). Interestingly, our group has previously demonstrated that a sigS mutant is significantly
more sensitive to the β-lactam antibiotics, ampicillin and penicillin-G. In connection with this,
RNAseq analysis of the ecfY null strain reveals an increase in expression of the gene mraY,
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which encodes a phospho-N-acetylmuramoyl-pentapeptie-transferase that catalyzes the initial
step in peptidoglycan biosynthesis. In B. subtilis, overexpression of mraY leads to an increase in
MIC for a number of cell wall targeting antibiotics (Ishizaki et al., 2013). These results would
suggest that σS is responsible for controlling expression of mraY in protecting S. aureus from
damage to the cell wall.
Conversely, we identified decrease in expression of atl, which encodes the major autolysin in S.
aureus (Foster, 1995). This autolysin is involved in cell wall turn over, contributing to the
separation of daughter cells following cell division and in antibiotic induced lysis (Biswas et al.,
2006), (Foster, 1995), (Sugai et al., 1997).

We have previously demonstrated that sigS

expression in induced following exposure to sodium dodecyl sulfate (SDS) and that sigS mutants
are more susceptible to lysis by Triton X-100 (Miller et al., 2012). These results suggest that σS
may be responsible for the transcription of genes that are involved in cell wall biosynthesis in
response to stress, while indirectly repressing the transcription of genes that are involved in
degradation of the cell wall.
Previous reports by our group have demonstrated that sigS expression is important in the
virulence of S. aureus using both ex vivo and in vivo models of infection (Miller et al., 2012),
(Shaw et al., 2008). We describe here that an ecfY null strain is more resistant to phagocyte
mediated killing when compared to the sigS mutant and wild-type strain, suggesting that sigS is
responsible for controlling the expression of genes that are involved in virulence. Along these
lines, in the ecfY null strain we observed an increase in expression of the accessory gene
regulator locus, agr, which encodes a two-component quorum sensing system important in
virulence in S. aureus (Morfeldt et al., 1988), (Peng et al., 1988). Abdelnour, et al. demonstrated
that agr is required for the establishment and development of septic arthritis in a murine model
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of infection, which mirrors our own findings with sigS mutants in this same model (Abdelnour et
al., 1993), (Shaw et al., 2008). These results indicate that σS may be involved in controlling the
expression of agr, and thus this may be the reason a sigS mutant is attenuated in virulence.
Additionally, RNAseq analysis reveals an increase in expression of a fibronectin binding protein
(SAUSA300_1101), which has been shown to be important in virulence. Wesson et. al. has
demonstrated that the ability of S. aureus to bind to host fibronectin greatly enhances the
internalization of this bacterium in nonprofessional phagocytes (Wesson et al., 1998). The
ability of S. aureus to persist in nonprofessional phagocytes contributes to dissemination to other
parts of the body, long term infection and resistance to antibiotics by hiding within host cells
(Löffler, Tuchscherr, Niemann, & Peters, 2014). Additionally, we observed an increase in
expression of a fibrinogen binding protein, clumping factor B in the ecfY knock down strain.
Previous studies have indicated that fibrinogen mediated adherences is crucial in virulence using
a rabbit model of endocarditis (Moreillon et al., 1995). These results suggest that σS may control
the expression of genes that are crucial in adherence of S. aureus to host cells, therefore
contributing to the internalization by nonprofessional phagocytes, perhaps leading to chronic
infection.

The success of S. aureus can, in part, be attributed to its ability to gain resistance to antibiotics.
Since the introduction of antibiotics, resistance by S. aureus to newly deployed agents is
commonly observed within 12 months (Davies, 2008).

Indeed, resistance to daptomycin

emerged before the FDA had even approved the drug (America., 2004). Vancomycin has
traditionally been used as a mainstay against MRSA infections; however, recently there has
emerged vancomycin-intermediate and vancomycin-resistant S. aureus (VISA and VRSA,
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respectively). With the rise in antibiotic resistance, it is becoming increasingly important to
develop new antibacterial agents. However, only seven new antibiotics were approved by the
US Food and Drug Administration (FDA) in the last decade, none of which had a novel
mechanism of action (Davies, 2008). Thus, the development of novel antimicrobial compounds
is a vital avenue of research in the fight against multi-drug resistant S. aureus. To this end,
several studies have indicated the use of quinazolines as potent antimicrobial compounds.
Quinazolines are an emerging class of compounds that have exhibited a number of
pharmacological activities, such as sedative, analgesic, antimalarial, antihypertensive,
antitumoral and antimicrobial (Bathini, Sidhu, Singh, Micetich, & Toogood, 2002), (Shiba, elKhamry, Shaban, & Atia, 1997). To this latter point, several studies have demonstrated that
quinazolines are active against a wide range of bacterial organisms, including Bacillus subtilis, S.
aureus, E. coli and P. aeruginosa (El-Gaby, 2000; Guan et al., 2005; He et al., 2012) (Mosaad,
Mohammed, Ahmed, & Abdel-Hamide, 2004). In this study we present the characterization of a
library of quinazolines by exploring their activity against multi-drug resistant S. aureus, their
mechanism of action, likelihood of resistance and efficacy in vivo.
In order to determine the effect of a library of quinazolines on multi-drug resistant S. aureus, we
used a Kirby Bauer (KB) assay. Using this method, we demonstrated that 53% of the library was
active against our HA-MRSA strain. While the KB assay has been a mainstay in determining
antimicrobial susceptibility, it can be considered a qualitative assay, revealing very little about
how potent many antimicrobial compounds are (El Feghaly, Stamm, Fritz, & Burnham, 2012).
In order to quantitate the activity of our library, we determined the minimum inhibitory
concentration (MIC), revealing that, while a number of compounds were active at very high
concentrations, five had MICs ranging from 0.01 µg ml-1 to 3 µg ml-1. Studies exploring the
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antimicrobial activity of another series of quinazoline derivatives revealed high levels of activity
against S. aureus with MICs of 6.25 µg ml-1, which is higher than the largest MIC we observed
for our quinazoline derivatives, thus indicating that our quinazolines are more active than those
currently described (Nosulenko et al., 2014).
We next evaluated the minimum bactericidal concentration of our lead quinazoline compounds,
and found that, whilst compounds 28, 32, 50 and 62 demonstrate varying degrees of bactericidal
activity, compound 53 demonstrated bacteriostatic activity. This is unusual as many derivatives
of the same chemotype share the same activity as the parent compound; however, we
demonstrate that compounds of the same class display not only varying degrees of bactericidal
activity but also different activity all together. This would indicate that these compounds are
behaving in a manner that is unique compared to other currently available antibiotics. The
debate over whether it is more important for an antimicrobial compound to have bacteriostatic or
bactericidal activity has been ongoing for many years (Finberg et al., 2004), (Pankey & Sabath,
2004). While bacteriostatic compounds are aided by the immune system when it comes to
clearing an infection, it has been well documented that this is not the case for
immunocompromised patients or patients inflicted with bacterial infections in the central nervous
system or the heart (Finberg et al., 2004). Therefore, in immunocompromised patients and those
that are suffering from endocarditis and meningitis, the use of an antibiotic that possesses
bactericidal activity are important in order to minimize the damage that may be caused due to
infection (Finberg et al., 2004).
An important attribute of antimicrobial compounds is their specificity for prokaryotic targets.
Therefore, we determined the cytotoxicity of our lead quinazolines using adenocarcinoma human
alveolar basal epithelial cells (A549). For compounds 28, 32, 50 and 53 we demonstrated that at
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all concentrations tested we recovered >50% of the A549 cells.

This suggests that our

compounds are not cytotoxic to human cells and the killing effect these compounds have on S.
aureus is specific. However, for compound 62 we observed that as the concentration increased
we recovered diminishing number of A549 cells. These results are not surprising, as quinazoline
derivatives have demonstrated to have potent activity against a number of human targets. Yong
et al. has demonstrated anti-cancer activity of quinazoline derivatives against A549 cells with an
IC50 value of 4.26 µM (Yong, Lu, & Wu, 2015). Additionally, studies indicate that quinazoline
derivatives inhibit tyrosine kinases, which are important in regulating a number of physiological
processes in both prokaryotes and eukaryotes (Grangeasse, Nessler, & Mijakovic, 2012), (Wilks,
1990).
S. aureus has the amazing ability to acquire resistance to antibiotics in a period of 6 to 12
months, making treatment of infections caused by this pathogen very difficult.

The most

common way a bacterium can acquire resistance is usually through the alteration of the target
(Barker, 1999), which can be accomplished through mutating the gene that encodes it. The rate
at which this occurs is referred to as the mutation frequency (Martinez & Baquero, 2000). Often
the mutation frequency can be instrumental in determining the success of an antibiotic, with most
currently approved agents falling in the range of 10-8 to 10-10 (Martinez & Baquero, 2000). We
evaluated the mutation frequency of our lead compounds and determined that resistance to 28,
32, and 62 was easily acquired. Conversely, for compounds 50 and 53 we observed mutation
frequencies of less than 1 X 10-11 and 3.03 X 10-10, respectively. These mutation frequencies are
lower than those determined for other quinazoline derivatives, for example Huband et. al. has
demonstrated that quinazoline-2, 4-dione derivatives have mutation frequencies of 3 X 10-7
against S. aureus (Huband et al., 2007).
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Next, we sought to identify the mechanism of action of our library of quinazoline
compounds. Because of the structural similarities of quinazoline and quinolones, we first
sequenced the quinolone resistant determining regions (QRDR) of our spontaneous mutants.
Quinolones interfere with the ability of a cell to unwind or coil its DNA, which is essential in
DNA replication (Deitz, Cook, & Goss, 1966). Huband et. al. has demonstrated that a series of
quinazoline-2,4-diones are gyrase and topoisomerase inhibitors and are active against a large
number of pathogens including S. aureus, Listeria monocytogenes, and Legionella pneumoniae
(Huband et al., 2007). When we sequenced the QRDR, we did not observe any mutation in these
regions of our spontaneous mutants compared to the wild-type, thus indicating that our
quinazoline derivatives are not gyrase or topoisomerase inhibitors.

Several studies have

indicated that quinazolines inhibit the enzyme dihydrofolate reductase (DHFR), which catalyzes
the conversion of dihydrofolate into tetrahydrofolate (THF) in the final step in folic acid
production, an essential process in bacteria (Bermingham & Derrick, 2002), (Blaney, Hansch,
Silipo, & Vittoria, 1984), (Ghose & Crippen, 1982). We sequenced the DHFR locus of our
spontaneous mutants and the wild-type strain in order to determine if these compounds inhibit
this enzyme. Upon analysis, we did not find any mutations in this locus in our mutant strains
compared to the wild-type, which would indicate that this is not the mechanism of action.
However, Van Horn et. al. previously characterized a series of quinazolines against the
eukaryote L. donovani that inhibit dihydropteroate synthase (DHPS). They observed that the
addition of exogenous para-aminobenzoic acid, which is a substrate of DHPS and essential in
folic acid production, rescued quinazoline-mediated killing of L. donovani (Van Horn et al.,
2014). Therefore, we hypothesized that if our quinazoline derivatives inhibit DHFR than the
addition of the end product THF should rescue S. aureus from quinazoline-mediated killing.
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Upon analysis, we observed that addition of exogenous THF to cells grown in the presence of a
lethal concentration of compounds 32, 50, 53, and 62 rescued the growth of S. aureus, even at
the lowest concentration of THF tested. These results were comparable with the known DHFR
inhibitor, trimethoprim, suggesting that these quinazolines are interfering with folic acid
production in S. aureus. This contrasts somewhat with the lack of mutations in the DHFR gene
for resistant strains, however it might be that the mechanism of resistance to these compounds is
mediated via efflux pumps; possibly via their overexpression. Indeed, S. aureus’ resistance to a
number of antibiotics, such as fluoroquinolones, tetracycline, and novobiocin, is mediated
through the use of such pumps (Costa, Viveiros, Amaral, & Couto, 2013).
The known DHFR inhibitor, trimethoprim, is always used in conjunction with another antibiotic
that targets the folic acid biosynthesis, sulfamethoxazole. This is because when trimethoprim
and sulfamethoxazole are used together they are synergistic, meaning together they are able to
achieve bacterial killing at lower MICs than each one individually. In addition, these two
compounds act at two separate steps in the biosynthesis of folate and create a toxic intermediate
(Gleckman, Alvarez, & Joubert, 1979). In regard to our library of quinazolines, because the
mechanism of action of these antimicrobials is through the inhibition of DHFR we were curious
to determine if they were synergistic with sulfamethoxazole. Therefore, we determined the
fractional inhibitory concentration (R. Manganelli et al.) of lead compounds and
sulfamethoxazole individually and in combination. The FIC was then used to calculate the
ΣFIC, demonstrating that our quinazoline derivatives act synergistic with sulfamethoxazole as
demonstrated by ΣFICs that are below the ≤ 0.5 threshold used to define synergism of two
agents.
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The major goal of this study was to identify novel antimicrobials that were efficacious in vivo.
Therefore, we first evaluated efficacy using a Galleria mellonella model of infection. We
observed a significant increase in survival of G. mellonella treated with either 5X or 10X the
MIC of our quinazolines, when compared to those that were untreated. Following this, we
assessed the efficacy of our lead quinazolines using an in vivo model of murine peritonitis. In so
doing we observed increased survival of mice that were treated with either compound 50 or 53
compared to those that were treated with the negative control. Further more, we observed an
increase in survival of mice that were treated with our quinazolines relative to those that were
treated with the positive control, vancomycin, thus indicating that our compounds are more
efficacious in vivo than the last line of defense antibiotic against multi-drug resistant S. aureus.
Thus, the results of our study demonstrate the potential of N2, N4-disubstituted quinazoline-2, 4diamines as an effective treatment option against infections caused by MRSA.

Future Directions. In this study, we demonstrate that the expression of sigS is influenced by a
number of different elements that are involved in the DNA damage response, and amino acid and
cell wall biosynthesis.

Specifically, we identified that CymR and KdpE bind to the sigS

promoter and represses transcription. Future work investigating the genetic regulation of sigS
will focus on exploring the relationship between these direct regulators and sigS. In order to do
this, we will construct a sigS cymR double mutant and evaluate this strains ability to survive
when exposed to chemical stressors that result in oxidative damage, as both sigS and cymR have
been shown to play a role in this type of stress (Miller et al., 2012), (Soutourina et al., 2010;
Soutourina et al., 2009). In addition, Soutourina et. al. has previously demonstrated that a cymR
mutant is better able to survive intracellularly after phagocytosis by RAW 264.7 cells, therefore,
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we hypothesize that this may result from increased sigS expression. In order to determine if this
is true, we will evaluate the ability of the sigS cymR double mutant to survive post-phagocytosis
when compared to the wild-type, a sigS mutant, and a cymR mutant. We expect that a sigS cymR
double mutant will display the same phenotype as a sigS mutant.
Also, our study reveals that sigS is regulated in a unique manner: positively by EcfX and
negatively by ecfY, through RNA-RNA mediated interaction. Therefore, future work regarding
this unique event will include investigating the interaction between σS and EcfX. Because σS is a
sigma factor and is required to associate with core-RNAP in order to function, we aim to
determine if EcfX can also associate with the RNAP complex. This will be performed using
nickel bead pull down assays, and various combinations of purified proteins. These assays will
be performed using EcfX with core-RNAP, σS and core-RNAP, EcfX and σS, core-RNAP by
itself, σS by itself and EcfX by itself. Our group has also previously demonstrated that σS is able
to bind to core-RNAP and initiate transcription from its own promoter (Shaw et al., 2008).
Therefore, in order to elucidate the involvement of EcfX in the initiation process we will perform
transcriptional run off experiments. These assays will be undertaken using EcfX with coreRNAP, σS and core-RNAP, EcfX and σS, core-RNAP by itself, σS by itself and EcfX by itself.
We will perform these assays with the promoter region of sigS, as we know that it can bind with
RNAP and initiate transcription from its own promoter.
In this present study, we provide evidence suggesting that ecfY is regulating sigS expression
through RNA-RNA interaction of the extended 3’ end of ecfY that is antisense to the transcript of
sigS. Therefore, future work would include demonstrating interaction between the ecfY and sigS
transcripts through enzymatic and chemical approaches. In the event that the extended 3’ end of
ecfY binds to the sigS transcript, it would be interesting to evaluate if an RNase has a role in
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degrading this double stranded RNA complex. This can be achieved by evaluating expression of
sigS in a mutant that lacks the rnc gene, which encodes the major RNase (RNaseIII) in S. aureus,
and comparing expression to the ecfY null strain and the wild-type. In addition, we would like to
evaluate the contribution ecfY makes to the pathogenesis of S. aureus using a murine model of
sepsis. In the present study, we demonstrated that an ecfY mutant is more resistant when
challenged with components of the innate immune response, while a sigS mutant is more
sensitive. We have previously demonstrated that a sigS mutant is attenuated in virulence using a
murine model of septic arthritis; therefore, our results suggest that an ecfY null strain would be
hypervirulent. Additionally, the results from our RNAseq analysis will be confirmed in context
of both sigS and ecfY. In order to confirm these results and to determine if it is due to the over
expression of sigS or a lack of ecfY, qPCR analysis will be performed on the wild-type strain, the
ecfY mutant, and the ecfY-S and ecfY-L complement strains. Moreover, for any genes determined
to be regulated by σS, we will also evaluate the impact that EcfX has on the expression of these
genes.

In addition, we will use a combination of bioinformatic and DNA foot printing

approaches to identify a consensus sequence for σS using genes that are determined to be
regulated by this sigma factor.
Future works regarding our quinazolines include assessing the in vivo efficacy of these drugs in
combination with sulfamethoxazole using murine systems. In addition, we aim to elucidate the
pharmacokinetic and pharmacodynamics properties of our quinazoline compounds.

With

regards to the pharmacokinetics, we will explore the absorption of our compounds, which
includes the bioavailability, distribution and elimination of the drugs. In addition, we will also
determine the area under the curve for serum concentration, and peak serum and trough levels of
the compounds in plasma and tissue of mice that have been exposed to our drugs. With regards
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to the pharmacodynamics of our compounds, we will determine the in vivo half-life and the
therapeutic window of our drugs. We have demonstrated in our study that these compounds
appear to inhibit DHFR; therefore, computer modeling will be performed in order to determine
how our quinazoline compounds bind to and inhibit DHFR. In addition, any information gained
from the computer modeling will be confirmed using purified DHFR and quinazolines in tandem
with X-ray crystallography.
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